https://www.pharmaceutical-business-review.com/news/vitalmax-develops-new-cholesterol-supplement-300412/ 2012-04-30T00:25:00+00:00 https://www.pharmaceutical-business-review.com/news/cellon-introduces-sterile-single-use-containers-for-biological-solutions-300412/ 2012-04-30T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-gsk-announce-nda-submission-for-arzerra-in-japan-300412/ 2012-04-30T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-wins-patent-infringement-suits-against-mylan-300412/ 2012-04-30T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-gains-notice-of-allowance-for-dme-drug-optina-patent-300412/ 2012-04-30T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaxis-gains-marketing-approval-for-cystic-fibrosis-therapy-in-europe-300412/ 2012-04-30T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-reports-positive-phase-iii-data-of-gammagard-liquid-300412/ 2012-04-30T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/droxidopa-shows-efficacy-against-neurogenic-orthostatic-hypotension-300412/ 2012-04-30T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/eckert-ziegler-constructs-new-production-facility-in-poland-300412/ 2012-04-30T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/ptag-seeks-license-to-set-up-retail-outlets-in-ghana-300412/ 2012-04-30T05:13:00+00:00 https://www.pharmaceutical-business-review.com/news/faes-farma-invida-sign-commercialization-agreement-for-bilastine-300412/ 2012-04-30T05:17:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-completes-inspection-of-cambrex-api-manufacturing-facility-300412/ 2012-04-30T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/somaxon-cj-cheiljedang-sign-silenor-commercialization-agreement-300412/ 2012-04-30T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/rbcc-amarantus-sign-loi-to-progress-parkinsons-disease-program-300412/ 2012-04-30T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/swole-sports-introduces-new-sports-nutrition-supplement-010512/ 2012-04-30T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/tkl-research-selects-medidata-clinical-trial-management-system-010512/ 2012-04-30T23:52:00+00:00 https://www.pharmaceutical-business-review.com/news/altor-mra-to-jointly-sponsor-studies-of-alt-803-against-metastatic-melanoma-010512/ 2012-05-01T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/igy-immune-technology-to-produce-purified-igy-products-010512/ 2012-05-01T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-unveils-generic-doryx-tablets-010512/ 2012-05-01T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/prana-initiates-phase-iia-huntington-disease-trial-010512/ 2012-05-01T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-settles-patent-infringement-litigation-with-mylan-010512/ 2012-05-01T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/tolero-mannkind-enter-into-licensing-agreement-for-btk-inhibitors-010512/ 2012-05-01T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-wins-31m-research-grant-from-israeli-government-010512/ 2012-05-01T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/aptar-launches-new-capsule-based-dpi-for-asthma-patients-010512/ 2012-05-01T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-to-relocate-kolliphor-tpgs-production-to-germany-010512/ 2012-05-01T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-signs-five-year-framework-agreement-with-kadimastem-010512/ 2012-05-01T04:52:00+00:00 https://www.pharmaceutical-business-review.com/news/zalicus-completes-enrollment-in-phase-iib-rheumatoid-arthritis-trial-010512/ 2012-05-01T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/purdue-pharma-adopts-realtime-biolock-system-020512/ 2012-05-02T00:01:00+00:00 https://www.pharmaceutical-business-review.com/news/anlit-advanced-nutrition-supplements-to-present-new-dietary-products-020512/ 2012-05-02T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-protalixpfizer-gaucher-drug-020512/ 2012-05-02T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-clostridium-difficile-molecular-diagnostic-test-020512/ 2012-05-02T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/immuven-wins-sbir-grant-to-develop-mrsa-therapeutics-020512/ 2012-05-02T02:01:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-yale-university-enter-into-drug-discovery-alliance-020512/ 2012-05-02T04:54:00+00:00 https://www.pharmaceutical-business-review.com/news/anaptysbio-gilead-partner-to-develop-antibody-therapeutics-020512/ 2012-05-02T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/beposone-shows-nasal-symptom-improvement-in-phase-2-study-020512/ 2012-05-02T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/inovio-wins-us-patent-for-cervical-dysplasia-cancer-vaccine-020512/ 2012-05-02T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-installs-ups-4-blister-line-at-us-packaging-facility-020512/ 2012-05-02T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/aptalis-cephalon-win-appeal-against-amrix-muscle-relaxant-patents-020512/ 2012-05-02T08:36:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-initiates-phase-iii-chronic-lymphocytic-leukemia-trial-020512/ 2012-05-02T08:40:00+00:00 https://www.pharmaceutical-business-review.com/news/lorus-genentech-announce-licensing-agreement-for-il-17e-in-cancer-020512/ 2012-05-02T08:46:00+00:00 https://www.pharmaceutical-business-review.com/news/hawthorn-pharma-deploys-fiberlink-mobile-cloud-platform-030512/ 2012-05-02T22:34:00+00:00 https://www.pharmaceutical-business-review.com/news/trevena-enters-into-research-partnership-with-merck-030512/ 2012-05-03T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-research-submits-new-drug-applications-to-fda-for-xarelto-030512/ 2012-05-03T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/aveo-announces-phase-2-data-of-lung-cancer-therapy-030512/ 2012-05-03T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/azelon-completes-clinical-trial-to-compare-nasal-spray-zt-034-to-forteo-030512/ 2012-05-03T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-to-invest-in-wilson-packaging-facility-030512/ 2012-05-03T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/acella-receives-approval-for-generic-gabapentin-oral-solution-030512/ 2012-05-03T09:57:00+00:00 https://www.pharmaceutical-business-review.com/news/js-genetics-launches-new-xcat-ks-buccal-swab-test-030512/ 2012-05-03T09:58:00+00:00 https://www.pharmaceutical-business-review.com/news/profectus-receives-grant-to-develop-trivalent-vaccine-against-ebola-marburg-viruses-030512/ 2012-05-03T10:01:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-announces-actemra-data-from-summacta-study-030512/ 2012-05-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/idera-reports-imo-2055-combination-therapy-results-030512/ 2012-05-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ec-grants-orphan-drug-designation-to-sunesis-vosaroxin-drug-030512/ 2012-05-03T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cara-chong-kun-sign-licensing-contract-for-analgesic-drug-candidate-040512/ 2012-05-04T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-awards-sbir-grant-for-genvec-rsv-vaccine-program-040512/ 2012-05-04T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-starts-enrollment-for-its-phase-i-bird-flu-vaccine-trial-040512/ 2012-05-04T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/sartorius-c-lecta-sign-distribution-contract-for-serratia-marcescens-nuclease-040512/ 2012-05-04T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/quanticate-deploys-comprehend-clinical-web-based-platform-040512/ 2012-05-04T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/zydus-chooses-revitas-flex-technology-platform-to-support-us-operations-040512/ 2012-05-04T02:57:00+00:00 https://www.pharmaceutical-business-review.com/news/linkage-biosciences-to-open-new-manufacturing-plant-in-california-040512/ 2012-05-04T04:27:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-take-over-certain-assets-of-university-medical-pharmaceuticals-040512/ 2012-05-04T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-to-obtain-ap214-rights-from-action-pharma-040512/ 2012-05-04T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-begins-phase-iii-hereditary-angioedema-study-040512/ 2012-05-04T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/metagenics-unveils-nutragems-coq10-300-chewable-gels-040512/ 2012-05-04T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/pain-therapeutics-wins-four-us-patents-for-remoxy-040512/ 2012-05-04T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-takes-over-doe-ingalls-management-040512/ 2012-05-04T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/vitalmax-revagard-supplement-could-improve-immune-system-070512/ 2012-05-06T23:34:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-begins-phase-ii-hypertriglyceridemia-study-with-isis-apociiirx-070512/ 2012-05-07T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phase-iii-lyrica-study-fails-to-meet-primary-efficacy-endpoint-070512/ 2012-05-07T00:24:00+00:00 https://www.pharmaceutical-business-review.com/news/breckenridge-signs-marketing-agreement-with-zhejiang-for-hiv-drug-070512/ 2012-05-07T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-announces-favorable-court-ruling-in-tarceva-patent-infringement-suit-070512/ 2012-05-07T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-sunovion-latuda-label-update-to-extend-dose-range-070512/ 2012-05-07T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/generon-commences-phase-ii-breast-cancer-trial-with-f-627-070512/ 2012-05-07T04:58:00+00:00 https://www.pharmaceutical-business-review.com/news/immuron-joins-synlait-to-produce-hyperimmune-colostrum-070512/ 2012-05-07T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-syngene-to-set-up-nutrition-rd-center-070512/ 2012-05-07T06:52:00+00:00 https://www.pharmaceutical-business-review.com/news/accellent-to-sell-pittsburgh-facility-to-perryman-070512/ 2012-05-07T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/adcock-opens-integrated-manufacturing-facility-in-south-africa-070512/ 2012-05-07T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/chesapeake-takes-over-pharmapost-from-cegedim-070512/ 2012-05-07T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/um-gains-funds-from-pii-for-technology-education-and-research-070512/ 2012-05-07T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-coherus-partner-to-develop-biosimilar-candidates-080412/ 2012-05-08T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-keryx-terminate-perifosine-license-agreement-080512/ 2012-05-08T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/vivus-wins-nda-approval-for-erectile-dysfunction-therapy-in-us-080512/ 2012-05-08T01:00:00+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-to-launch-zetonna-nasal-aerosol-for-allergic-rhinitis-080512/ 2012-05-08T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/rbc-life-sciences-announces-financial-results-for-q1-2012-080512/ 2012-05-08T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-yakuhin-santen-ink-co-promotion-deal-for-eylea-in-japan-080512/ 2012-05-08T04:21:00+00:00 https://www.pharmaceutical-business-review.com/news/enzon-zhejiang-sign-licensing-deal-for-pegylation-linker-technology-080512/ 2012-05-08T05:27:00+00:00 https://www.pharmaceutical-business-review.com/news/everett-launches-new-reproductive-support-dietary-supplement-080512/ 2012-05-08T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/celsion-enters-thermodox-supply-agreement-with-hisun-pharma-080512/ 2012-05-08T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ariosa-announces-availability-of-harmony-prenatal-test-in-us-canada-080412/ 2012-05-08T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/hbi-prometic-sign-strategic-manufacturing-deal-080512/ 2012-05-08T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-clinigen-snda-for-foscavir-080512/ 2012-05-08T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-reports-positive-results-from-phase-iii-study-with-pasireotide-080512/ 2012-05-08T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/multivac-to-present-new-packaging-machine-concept-090512/ 2012-05-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/basilea-selects-dotmatics-suite-of-scientific-informatics-solutions-080512/ 2012-05-08T19:28:00+00:00 https://www.pharmaceutical-business-review.com/news/spanish-firm-adopts-cegedim-mobile-intelligence-platform-090512/ 2012-05-08T22:25:00+00:00 https://www.pharmaceutical-business-review.com/news/envoy-wins-additional-mjff-grant-to-advance-research-080512/ 2012-05-09T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-unveils-generic-version-of-lipitor-in-uk-090512/ 2012-05-09T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/monsanto-enters-into-licensing-contract-with-marina-090512/ 2012-05-09T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/genta-initiates-tesegast-trial-with-tesetaxel-in-gastric-cancer-patients-090512/ 2012-05-09T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-increases-availability-of-optison-suspension-090512/ 2012-05-09T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/niaid-awards-biodefense-grant-for-antiviral-drug-development-090512/ 2012-05-09T05:07:00+00:00 https://www.pharmaceutical-business-review.com/news/morinda-unveils-new-line-of-fit-body-composition-supplements-090512/ 2012-05-09T05:56:00+00:00 https://www.pharmaceutical-business-review.com/news/pozen-signs-licensing-deal-with-desitin-for-mt-400-migraine-therapy-090512/ 2012-05-09T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-wins-israeli-government-grant-to-advance-oral-insulin-studies-090512/ 2012-05-10T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-confirms-anda-filing-to-market-shire-lialda-100412/ 2012-05-10T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/basf-takes-over-equateq-100512/ 2012-05-10T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-to-offer-antibody-discovery-development-service-to-4-antibody-100512/ 2012-05-10T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-arthritis-advisory-committee-recommends-approval-of-pfizer-tofacitinib-100512/ 2012-05-10T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/gtg-signs-settlement-licensing-agreement-with-geneseek-100512/ 2012-05-10T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-fda-approval-for-xarelto-100512/ 2012-05-10T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/millennium-seattle-genetics-commence-phase-iii-ctcl-trial-100512/ 2012-05-10T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/medgenics-wins-israeli-government-grant-to-support-rd-expenses-100512/ 2012-05-10T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/dsp-announces-positive-results-from-phase-iii-trials-with-latuda-100512/ 2012-05-10T02:34:00+00:00 https://www.pharmaceutical-business-review.com/news/sk-biopharmaceuticals-signs-licensing-deal-with-hanmi-for-dzns-technology-100512/ 2012-05-10T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/iavi-glycomimetics-and-gd-to-develop-hiv-vaccine-100512/ 2012-05-10T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/lantheus-signs-manufacturing-agreement-with-jhs-100512/ 2012-05-10T06:17:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-plans-new-drug-production-facilities-in-nigeria-malaysia-100512/ 2012-05-10T06:23:00+00:00 https://www.pharmaceutical-business-review.com/news/unipex-group-takes-over-debro-pharma-100512/ 2012-05-10T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/zygem-to-integrate-enzymatic-technology-into-quanta-pcr-kits-100512/ 2012-05-10T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cegedim-provides-cloud-based-solution-to-laboratorios-rubi-110512/ 2012-05-10T21:19:00+00:00 https://www.pharmaceutical-business-review.com/news/therapeuticsmd-launches-chewable-prescription-prenatal-vitamin-110512/ 2012-05-10T23:04:00+00:00 https://www.pharmaceutical-business-review.com/news/biosyent-launches-sterile-topical-anesthetic-in-canada-110512/ 2012-05-11T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/cell-therapeutics-pixuvri-receives-european-union-approval-110512/ 2012-05-11T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/ge-healthcare-acquires-xcellerex-110512/ 2012-05-11T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-extends-lorcaserin-marketing-alliance-with-eisai-110512/ 2012-05-11T02:41:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-symbicort-shows-similar-safety-profile-as-budesonide-for-asthma-110512/ 2012-05-11T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ista-pharma-presents-prolensas-phase-3-clinical-data-110512/ 2012-05-11T02:54:00+00:00 https://www.pharmaceutical-business-review.com/news/cvs-caremark-division-unveils-two-medical-clinics-in-san-antonio-110512/ 2012-05-11T03:23:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-aln-ttr01-drug-shows-efficacy-in-phase-i-study-110512/ 2012-05-11T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/seattle-genetics-announces-phase-ii-clinical-trial-results-for-adcetris-110512/ 2012-05-11T04:32:00+00:00 https://www.pharmaceutical-business-review.com/news/viztek-launches-new-web-based-integrated-mammography-suite-140512/ 2012-05-13T23:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-recommends-gilead-hiv-drug-140512/ 2012-05-14T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-unveils-generic-lipitor-tablets-in-europe-140512/ 2012-05-14T00:35:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-reaches-milestone-under-research-collaboration-with-ironwood-140512/ 2012-05-14T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-stiefel-nda-for-fabior-foam-01-140512/ 2012-05-14T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/target-health-unveils-new-vct-database-registry-140512/ 2012-05-14T03:00:00+00:00 https://www.pharmaceutical-business-review.com/news/angel-biotech-acquires-collagen-plant-in-uk-140512/ 2012-05-14T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/isco-develops-new-stem-cell-production-methods-140512/ 2012-05-14T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-commences-phase-iia-rheumatoid-arthritis-study-140512/ 2012-05-14T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-phase-iii-crohns-disease-trial-meets-primary-endpoints-140512/ 2012-05-14T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/liquid-health-unveils-new-weight-management-formula-140412/ 2012-05-14T05:23:00+00:00 https://www.pharmaceutical-business-review.com/news/arno-gains-orphan-drug-status-for-ar-42-in-europe-140512/ 2012-05-14T08:06:00+00:00 https://www.pharmaceutical-business-review.com/news/inc-research-selects-transperfect-trial-interactive-technology-150512/ 2012-05-15T00:08:00+00:00 https://www.pharmaceutical-business-review.com/news/private-label-unveils-green-coffee-bean-extract-formulations-150512/ 2012-05-15T00:20:00+00:00 https://www.pharmaceutical-business-review.com/news/maxygen-to-receive-30m-payment-from-bayer-150512/ 2012-05-15T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/bp-investments-unveils-new-energy-weight-loss-supplements-150512/ 2012-05-15T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/novozymes-biopharma-initiates-production-of-hyaluronic-acid-150512/ 2012-05-15T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-tsinghua-university-sign-multi-year-strategic-partnership-150512/ 2012-05-15T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/furiex-menarini-sign-licensing-deal-to-commercialize-priligy-150512/ 2012-05-15T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-begins-phase-iii-liver-cancer-study-with-livatag-150512/ 2012-05-15T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/critical-diagnostics-appoints-two-new-distributors-in-asia-pacific-region-150512/ 2012-05-15T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/cst-develops-new-monoclonal-antibody-discovery-platform-150512/ 2012-05-15T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/julphar-breaks-ground-on-32m-algerian-facility-150512/ 2012-05-15T05:41:00+00:00 https://www.pharmaceutical-business-review.com/news/ohr-wins-composition-of-matter-patents-in-us-europe-150512/ 2012-05-15T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/sch-grants-approval-to-manufacture-import-drugs-150512/ 2012-05-15T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/mitsubishi-to-withdraw-from-fine-chemical-business-160512/ 2012-05-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/creative-edge-nutrition-acquires-science-defined-nutrition-160512/ 2012-05-15T23:36:00+00:00 https://www.pharmaceutical-business-review.com/news/diagenic-wins-nok78m-grant-to-develop-blood-based-diagnostics-160512/ 2012-05-16T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-bristol-myers-biologics-manufacturing-facility-in-devens-160512/ 2012-05-16T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/debiopharm-vifor-sign-distribution-deal-in-switzerland-160512/ 2012-05-16T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phase-iii-renal-cell-carcinoma-study-fails-to-meet-primary-endpoint-160512/ 2012-05-16T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/scil-ono-partner-to-develop-affilin-therapeutics-160512/ 2012-05-16T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-therapeutics-to-implement-ross-enterprise-solution-160512/ 2012-05-16T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/achillion-gains-fda-fast-track-designation-for-ns5a-inhibitor-against-hcv-160512/ 2012-05-16T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/bg-medicine-files-for-expanded-indication-of-bgm-galectin-3-test-160512/ 2012-05-16T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-launches-new-therapy-to-eradicate-h-pylori-160512/ 2012-05-16T05:08:00+00:00 https://www.pharmaceutical-business-review.com/news/ais-hmi-terminals-optimize-cip-in-pharmaceutical-plants-160512/ 2012-05-16T08:03:00+00:00 https://www.pharmaceutical-business-review.com/news/pulmatrix-isperse-demonstrates-capability-to-formulate-drugs-160512/ 2012-05-16T08:16:00+00:00 https://www.pharmaceutical-business-review.com/news/s1-biopharma-forays-into-male-sexual-health-160512/ 2012-05-16T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/specialty-pharma-firms-deploy-model-n-sales-and-marketing-solution-170512/ 2012-05-16T23:40:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-aveo-announce-positive-results-from-tivo-1-advanced-rcc-study-170512/ 2012-05-17T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/avalanche-lonza-join-forces-for-adeno-associated-viral-vector-production-170512/ 2012-05-17T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-adds-solid-phase-extraction-technology-to-screening-facilities-170512/ 2012-05-17T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/cytodyn-completes-production-of-fiv-monoclonal-antibodies-170512/ 2012-05-17T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/aegis-wins-us-patent-covering-pth-pth-analogue-compositions-170512/ 2012-05-17T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/codexis-gains-us-patent-for-biocatalysts-biocatalytic-processes-170512/ 2012-05-17T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/ind-swift-with-wockhardt-launches-atorvastatin-tablets-in-uk-170512/ 2012-05-17T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/piramal-healthcare-to-take-over-drg-170512/ 2012-05-17T05:03:00+00:00 https://www.pharmaceutical-business-review.com/news/oramed-wins-israeli-patent-for-core-delivery-technology-170512/ 2012-05-17T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-gains-approval-for-advate-in-china-170512/ 2012-05-17T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/frutarom-unveils-new-line-of-ingredients-for-immune-health-market-170512/ 2012-05-17T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/florida-biologix-helps-taiwan-university-hospital-achieve-manufacturing-objectives-170512/ 2012-05-17T08:07:00+00:00 https://www.pharmaceutical-business-review.com/news/accelrys-buys-web-based-drug-discovery-solution-from-scynexis-180512/ 2012-05-17T23:15:00+00:00 https://www.pharmaceutical-business-review.com/news/reflex-nutrition-introduces-vegan-protein-powder-180512/ 2012-05-17T23:29:00+00:00 https://www.pharmaceutical-business-review.com/news/emergent-wins-fda-approval-for-change-in-biothrax-administration-schedule-180512/ 2012-05-18T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-anda-for-clopidogrel-tablets-180512/ 2012-05-18T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/ambit-teva-announce-fda-clearance-of-cep-32496-180512/ 2012-05-18T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/esperance-initiates-phase-ii-advanced-ovarian-cancer-trial-180512/ 2012-05-18T01:28:00+00:00 https://www.pharmaceutical-business-review.com/news/novabay-initiates-phase-iib-adenoviral-conjunctivitis-study-180512/ 2012-05-18T03:04:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-tapentadol-drug-found-to-reduce-pain-in-dpn-patients-180512/ 2012-05-18T04:55:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-introduces-irinotecan-injection-in-single-dose-vials-180512/ 2012-05-18T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/alpvision-nolato-partner-to-protect-pharmaceutical-primary-plastic-packaging-180512/ 2012-05-18T05:12:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-begins-phase-ii-nhl-study-with-zevalin-180512/ 2012-05-18T05:16:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-outlines-systems-based-pharmaceutics-vision-in-london-180512/ 2012-05-18T07:58:00+00:00 https://www.pharmaceutical-business-review.com/news/progenra-deploys-dotmatics-drug-research-platform-210512/ 2012-05-20T23:16:00+00:00 https://www.pharmaceutical-business-review.com/news/vitalmax-develops-new-immune-support-formula-210512/ 2012-05-20T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-generic-version-of-plavix-in-us-210512/ 2012-05-21T00:38:00+00:00 https://www.pharmaceutical-business-review.com/news/german-regulatory-authority-approves-helix-trial-of-topical-interferon-alpha-2b-210512/ 2012-05-21T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-perrigo-anda-for-lansoprazole-capsules-210512/ 2012-05-21T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/dci-wins-fda-approval-for-pertzye-nda-210512/ 2012-05-21T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/arqule-daiichi-complete-patient-recruitment-in-phase-iii-nsclc-trial-210512/ 2012-05-21T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/actavis-wins-fda-approval-for-ropinirole-extended-release-tablets-210512/ 2012-05-21T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/aegis-wins-us-patent-for-octreotide-formulations-210512/ 2012-05-21T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-confirms-filing-of-anda-for-generic-version-of-lo-loestrin-fe-with-fda-210512/ 2012-05-21T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-reports-positive-data-from-lubiprostone-drug-trials-210512/ 2012-05-21T07:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectis-introduces-human-ips-derived-hepatocyte-product-210512/ 2012-05-21T07:28:00+00:00 https://www.pharmaceutical-business-review.com/news/active-biotech-ipsen-reach-10m-milestone-in-phase-iii-study-of-tasquinimod-210512/ 2012-05-21T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/cipla-qcil-plans-50m-expansion-in-uganda-240512/ 2012-05-21T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/chdi-lundbeck-collaborate-for-huntingtons-disease-therapy-research-220512/ 2012-05-22T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/aushon-plans-to-launch-new-multiplex-protein-biomarker-platform-220512/ 2012-05-22T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/intermune-signs-deal-with-vidara-therapeutics-to-divest-actimmune-220512/ 2012-05-22T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-state-plans-non-generic-drugs-procurement-for-government-hospitals-220512/ 2012-05-22T02:42:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-girindus-sign-oligonucleotide-development-deal-220512/ 2012-05-22T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/period-vitamin-unveils-second-version-pms-supplement-220512/ 2012-05-22T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-form-cancer-research-alliance-with-national-cancer-center-220512/ 2012-05-22T04:04:00+00:00 https://www.pharmaceutical-business-review.com/news/xiangxue-pharma-to-acquire-kx02-licensing-rights-from-kinex-220512/ 2012-05-22T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/pulmatrix-presents-icalm-clinical-study-results-220512/ 2012-05-22T08:43:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-glaxosmithkline-to-co-promote-testim-in-us-220512/ 2012-05-22T08:48:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-phase-ii-type-2-diabetes-study-meets-primary-endpoint-230512/ 2012-05-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-xencor-complete-patient-enrollment-in-phase-i-cll-trial-230512/ 2012-05-22T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/relay-technology-launches-real-time-data-visualization-solution-230512/ 2012-05-22T22:53:00+00:00 https://www.pharmaceutical-business-review.com/news/adienne-pharma-signs-manufacturing-deal-with-selexis-230512/ 2012-05-23T00:37:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-onyx-phase-iii-nsclc-trial-fails-to-meet-primary-endpoint-230512/ 2012-05-23T00:42:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-astellas-submit-enzalutamide-nda-to-fda-230512/ 2012-05-23T00:46:00+00:00 https://www.pharmaceutical-business-review.com/news/accuray-dkfz-sign-master-research-collaboration-agreement-230512/ 2012-05-23T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/intellicell-signs-stem-cell-tissue-repair-research-deal-with-university-of-florida/ 2012-05-23T01:37:00+00:00 https://www.pharmaceutical-business-review.com/news/codexis-extends-process-development-collaboration-with-merck-230512/ 2012-05-23T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/btg-wins-european-marketing-rights-for-wellstat-uridine-triacetate-230512/ 2012-05-23T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/elite-wins-us-patent-covering-formulation-for-abuse-resistant-products-230512/ 2012-05-23T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-extended-use-of-novo-nordisk-levemir-insulin-in-children-230512/ 2012-05-23T04:20:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-presents-positive-results-from-phase-iii-obd-trial-230512/ 2012-05-23T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/thermogenesis-receives-approval-for-axp-autoxpress-platform-in-thailand/ 2012-05-23T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/us-health-department-supports-phase-3-study-of-smallpox-vaccine-230512/ 2012-05-23T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/provence-neuroptis-join-forces-to-optimize-transfer-ml7-production-process-230512/ 2012-05-23T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/eckerd-peru-implements-logfire-warehouse-management-solution-240512/ 2012-05-23T23:39:00+00:00 https://www.pharmaceutical-business-review.com/news/goose-introduces-pharma-project-management-solution-240512/ 2012-05-23T23:45:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-pbl-sign-licensing-agreement-for-baulcombe-hamilton-rnai-patent-240512/ 2012-05-24T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-launches-generic-antiretroviral-therapy-in-us-240512/ 2012-05-24T01:03:00+00:00 https://www.pharmaceutical-business-review.com/news/xdx-labcorp-sign-new-collaboration-license-agreement/ 2012-05-24T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/akrimax-introduces-exogenous-obesity-management-drugs-240512/ 2012-05-24T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/abd-serotec-to-introduce-hucal-anti-drug-antibodies-240512/ 2012-05-24T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-files-nda-with-fda-for-metastatic-colorectal-cancer-therapy-240512/ 2012-05-24T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/xennex-biotime-introduce-genecards-version-308-240512/ 2012-05-24T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/micurx-wins-composition-of-matter-patent-for-antibacterial-oxazolidinone-240512/ 2012-05-24T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-biogen-tysabri-label-change-240512/ 2012-05-24T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/raybiotech-signs-new-master-services-agreement-240512/ 2012-05-24T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/jarrow-formulas-launches-phospholipid-bound-omega-3-supplement-240512/ 2012-05-24T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/gw-initiates-phase-iii-sativex-cancer-pain-trial-240512/ 2012-05-24T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/medochemie-deploys-cegedim-cloud-based-crm-solution-250512/ 2012-05-25T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/app-buys-three-injectable-products-from-nexus-250512/ 2012-05-25T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-aurobindo-pharma-generic-hiv-drug-250512/ 2012-05-25T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/sun-pharmaceutical-gains-fda-approval-for-azelastine-hcl-nasal-spray-250512/ 2012-05-25T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-to-take-over-certain-assets-from-swiss-herbal-250512/ 2012-05-25T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-osteoporosis-drug-in-uk-italy-250512/ 2012-05-25T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/c3-jian-soon-to-initiate-phase-i-trial-of-c16g2-250512/ 2012-05-25T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/cellectricon-introduces-cellaxess-discovery-platform-250512/ 2012-05-25T05:19:00+00:00 https://www.pharmaceutical-business-review.com/news/several-chinese-pharma-firms-manufacture-unsafe-drug-capsules-250512/ 2012-05-25T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/auxilium-fcb-file-patent-infringement-lawsuit-against-watson-250512/ 2012-05-25T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/xenoport-submits-ind-application-to-commence-xp23829-clinical-studies-250512/ 2012-05-25T06:54:00+00:00 https://www.pharmaceutical-business-review.com/news/us-senate-passes-drug-import-safety-bill-290512/ 2012-05-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/true-diagnostics-to-distribute-truedx-platform-tsh-test-in-europe-280512/ 2012-05-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-renal-cell-carcinoma-therapy-receives-positive-opinion-from-chmp-280512/ 2012-05-28T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/sihuan-roxatidine-passes-on-site-inspection-for-drug-registration-in-china-280512/ 2012-05-28T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/cipher-gains-fda-approval-for-absorica-280512/ 2012-05-28T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-receives-positive-chmp-opinion-for-kalydeco-280512/ 2012-05-28T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-to-introduce-new-over-the-counter-skin-nutraceutical-product-line-280512/ 2012-05-28T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/apricus-wins-patent-allowances-for-nexact-technology-280512/ 2012-05-28T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/sar236553regn727-drug-found-to-lower-ldl-c-levels-280512/ 2012-05-28T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/absolute-nutrition-develops-new-diet-supplement-280512/ 2012-05-28T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-to-launch-cipher-absorica-in-us-280512/ 2012-05-28T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/summit-doses-first-cohort-of-patients-in-smt-c1100-study-280512/ 2012-05-28T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-to-take-over-multilab-in-brazil-280512/ 2012-05-28T06:49:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-state-drugs-control-department-seizes-24-not-of-standard-quality-drugs-280512/ 2012-05-28T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-begins-phase-i-trial-of-miv-711-280512/ 2012-05-28T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-receives-positive-chmp-opinion-for-fycompa-290512/ 2012-05-29T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/genmab-achieves-milestone-for-filing-arzerra-nda-in-japan-290512/ 2012-05-29T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/nuvo-research-paladin-sign-license-agreement-for-synera-in-canada-290512/ 2012-05-29T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-orphan-drug-status-for-andromeda-diabetes-therapy-290512/ 2012-05-29T01:31:00+00:00 https://www.pharmaceutical-business-review.com/news/cirm-funds-city-of-hope-to-develop-t-cell-based-therapy-290512/ 2012-05-29T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-pharma-industry-faces-gelatine-shortage-290512/ 2012-05-29T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/teralys-capital-eli-lilly-invest-in-150m-fund-290612/ 2012-05-29T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/peru-seizes-drug-manufacturing-chemicals-290512/ 2012-05-29T04:44:00+00:00 https://www.pharmaceutical-business-review.com/news/acacia-reports-positive-results-from-phase-ii-study-of-apd421-290512/ 2012-05-29T06:20:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-clears-roche-cancer-drug-mabthera-290512/ 2012-05-29T06:22:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-not-to-launch-generic-lipitor-290512/ 2012-05-29T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/pro-bono-polytherics-expand-haematology-alliance-290512/ 2012-05-29T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/cardinal-health-introduces-pathware-decision-transaction-solutions-300512/ 2012-05-29T22:01:00+00:00 https://www.pharmaceutical-business-review.com/news/biopharm-introduces-new-drug-safety-signal-detection-management-software/ 2012-05-29T23:23:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-receives-fda-approval-for-generic-lipitor-anda-300512/ 2012-05-30T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/ensemble-genentech-sign-drug-discovery-collaboration-300512/ 2012-05-30T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-sunovion-settle-patent-litigation-suit/ 2012-05-30T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/raptor-acquires-exclusive-rights-to-intellectual-property-from-mcgill-university-300512/ 2012-05-30T01:59:00+00:00 https://www.pharmaceutical-business-review.com/news/marshall-edwards-reports-dosing-first-cohort-of-patients-in-phase-i-me-344-trial-300512/ 2012-05-30T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/bms-joins-with-cancer-research-institutions-to-advance-science-of-immuno-oncology-300512/ 2012-05-30T03:30:00+00:00 https://www.pharmaceutical-business-review.com/news/un-orders-afghanistan-to-control-opium-production-300512/ 2012-05-30T03:31:00+00:00 https://www.pharmaceutical-business-review.com/news/advaxis-completes-patient-enrollment-in-phase-ii-trial-of-adxs-hpv-300512/ 2012-05-30T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/soricimed-gains-clearance-for-phase-i-trial-of-sor-c13-300512/ 2012-05-30T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/corgenix-receives-additional-us-patent-for-aspirinworks-technology-300512/ 2012-05-30T05:57:00+00:00 https://www.pharmaceutical-business-review.com/news/redhill-bioequivalence-trial-with-rhb-103-meets-specified-endpoints-300512/ 2012-05-30T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-to-sell-us-commercial-packaging-operations-040612/ 2012-05-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-canada-launches-alk-positive-advanced-or-metastatic-nsclc-therapy-310512/ 2012-05-31T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-dyax-extend-partnership-for-antibody-phage-display-technology-310512/ 2012-05-31T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-ono-enter-into-additional-target-discovery-agreement-310512/ 2012-05-31T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-injexs-needle-free-injection-technology-310512/ 2012-05-31T01:39:00+00:00 https://www.pharmaceutical-business-review.com/news/aptargroup-to-take-over-stelmi-310512/ 2012-05-31T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-tris-dextromethorphan-polistirex-extended-release-oral-suspension-310512/ 2012-05-31T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/exelixis-submits-cabozantinib-nda-to-fda-310512/ 2012-05-31T04:37:00+00:00 https://www.pharmaceutical-business-review.com/news/stiefel-to-acquire-development-commercialization-rights-to-welichem-wbi-1001-310512/ 2012-05-31T05:00:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-unveils-new-female-supplement-310512/ 2012-05-31T05:11:00+00:00 https://www.pharmaceutical-business-review.com/news/taiho-to-begin-phase-iii-colorectal-cancer-trial-with-tas-102-310512/ 2012-05-31T05:26:00+00:00 https://www.pharmaceutical-business-review.com/news/ariana-establishes-new-office-in-cambridge-massachusetts-010612/ 2012-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fortebio-unveils-new-dip-and-read-ni-nta-biosensor-040612/ 2012-05-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-to-establish-new-pilot-plant-facility-in-germany-010612/ 2012-06-01T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-initiates-pk-substudy-in-phase-iii-program-of-pharmacosurgery-product-010612/ 2012-06-01T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-submits-nda-to-fda-for-type-2-diabetes-therapy-010612/ 2012-06-01T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/rbi-to-progress-human-testing-of-appligel-g-in-dfu-management-010612/ 2012-06-01T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/oncothyreon-commences-phase-12-melanoma-trial-of-px-866-010612/ 2012-06-01T02:45:00+00:00 https://www.pharmaceutical-business-review.com/news/csl-behring-submitted-application-to-ema-for-privigen-010612/ 2012-06-01T05:09:00+00:00 https://www.pharmaceutical-business-review.com/news/medivation-astellas-eap-for-enzalutamide-gets-fda-clearance-010512/ 2012-06-01T05:14:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-opens-new-diabetes-focused-rd-center-in-china-010612/ 2012-06-01T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/esk-ceramics-obtains-minority-interest-in-chemtrix-010612/ 2012-06-01T07:35:00+00:00 https://www.pharmaceutical-business-review.com/news/forest-laboratories-nabriva-partner-to-develop-antibacterial-agent-010612/ 2012-06-01T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/talon-initiates-phase-3-confirmatory-study-of-marqibo-010612/ 2012-06-01T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-therapeutics-deploys-dotmatics-enterprise-platform-040612/ 2012-06-03T20:24:00+00:00 https://www.pharmaceutical-business-review.com/news/gcc-signs-five-year-software-licensing-agreement-with-accelrys-040612/ 2012-06-03T22:43:00+00:00 https://www.pharmaceutical-business-review.com/news/arqule-daiichi-announce-positive-results-from-phase-2-hcc-study-040612/ 2012-06-04T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/bmy-reports-interim-results-from-phase-1-trial-of-anti-pd-1-immunotherapy-040612/ 2012-06-04T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/avid-eli-lilly-announce-availability-of-amyvid-in-us-040612/ 2012-06-04T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-seeks-regulatory-approvals-for-eltrombopag-in-us-europe-040612/ 2012-06-04T04:09:00+00:00 https://www.pharmaceutical-business-review.com/news/full-motion-sports-to-develop-energize-pro-sports-drink-040612/ 2012-06-04T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/cardinal-health-to-manufacture-distribute-eli-lilly-diagnostic-imaging-agent-040612/ 2012-06-04T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/agendia-unveils-coloprint-microarray-signature-040612/ 2012-06-04T05:15:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-drais-enter-into-second-rd-partnership-040612/ 2012-06-04T05:21:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-reports-positive-results-from-phase-1b2-trial-with-inno-206-040612/ 2012-06-04T05:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ziopharm-completes-enrollment-in-picasso-3-trial-040612/ 2012-06-04T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/mexico-orders-riger-naturals-to-recall-reumofan-plus-natural-dietary-supplement-040612/ 2012-06-04T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/silicon-opens-laboratory-facilities-in-san-diego-040612/ 2012-06-04T07:06:00+00:00 https://www.pharmaceutical-business-review.com/news/htg-molecular-collaborates-with-jwci-to-market-melanoma-signature-assays-040612/ 2012-06-04T07:12:00+00:00 https://www.pharmaceutical-business-review.com/news/hi-tech-acquires-cormax-brand-rights-from-watson-040612/ 2012-06-04T07:42:00+00:00 https://www.pharmaceutical-business-review.com/news/ortho-clinical-receives-ce-mark-for-new-vitros-vitamin-d-total-assay-040612/ 2012-06-04T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/irqs-grants-iso-90012008-accreditation-for-inventys-research-butibori-plant-050612/ 2012-06-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/baxter-chatham-partner-to-develop-hemophilia-b-gene-therapy-treatment-050612/ 2012-06-05T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/invitria-to-develop-defined-cell-culture-media-for-cell-based-vaccine-production-050612/ 2012-06-05T02:09:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-lux-lung-3-phase-iii-trial-meets-primary-endpoint-040612/ 2012-06-05T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/cytochroma-mtpc-terminate-lunacalcipol-licensing-agreement-050612/ 2012-06-05T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-receives-eur4m-milestone-payment-from-boehringer-050612/ 2012-06-05T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/exonhit-receives-financial-support-from-oseo-050612/ 2012-06-05T04:29:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-to-commence-phase-2-major-depressive-disorder-study-with-adx71149-050612/ 2012-06-05T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/bioenergy-gains-b-level-brc-certification-for-manufacturing-facility-in-china-050612/ 2012-06-05T07:00:00+00:00 https://www.pharmaceutical-business-review.com/news/oncs-signs-cgmp-manufacturing-agreement-with-vgxi-050612/ 2012-06-05T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/piramal-sets-up-ma-team-for-expansion-050612/ 2012-06-05T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-bioinvent-regain-global-rights-to-tb-403-from-roche-050612/ 2012-06-05T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/paladin-files-non-traditional-pla-for-travelan-in-canada-060612/ 2012-06-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-unveils-new-weight-loss-supplement-060612/ 2012-06-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cardium-selects-amri-as-aseptic-fill-manufacturer-of-excellagen-060612/ 2012-06-06T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/kythera-earns-158m-payment-from-bayer-under-atx-101-licensing-deal-060612/ 2012-06-06T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-america-takes-over-url-pharma-060612/ 2012-06-06T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/dolbey-alpha-systems-enter-into-strategic-partnership-060612/ 2012-06-06T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/eckert-ziegler-gains-manufacturing-authorization-for-gallium-68-generators-060612/ 2012-06-06T07:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lupin-suprax-capsules-400mg-060612/ 2012-06-06T07:09:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-commences-endometriosis-oral-drug-phase-3-study-060612/ 2012-06-06T09:11:00+00:00 https://www.pharmaceutical-business-review.com/news/mhra-grants-marketing-authorization-for-psivida-iluvien-insert-060612/ 2012-06-06T09:13:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-health-to-purchase-shares-in-israeli-hepatitis-b-vaccine-manufacturer-060612/ 2012-06-06T09:16:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-two-notices-of-allowance-for-biolinerx-neuropathic-pain-therapy-060612/ 2012-06-06T09:17:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-wins-approval-for-generic-tracleer-in-canada-070612/ 2012-06-07T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-merck-collaborate-to-develop-biosimilar-compounds-070612/ 2012-06-07T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/dyax-signs-distribution-contract-with-taiba-for-kalbitor-in-middle-east-070612/ 2012-06-07T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/morphosys-receives-clinical-milestone-payment-from-roche-070612/ 2012-06-07T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-introduces-toviaz-in-canada-070612/ 2012-06-07T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/orexo-and-prostrakan-reconfigure-commercial-rights-to-abstral-070612/ 2012-06-07T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/intrexon-oragenics-to-develop-commercialize-lantibiotics-070612/ 2012-06-07T05:28:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-epivir-tablets-in-uk-italy-070612/ 2012-06-07T05:31:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-perrigo-anda-for-calcium-acetate-capsules-070612/ 2012-06-07T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/vasgenes-recombinant-fusion-protein-ready-for-phase-i-trial-070612/ 2012-06-07T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-completes-production-on-first-run-of-azul-instant-080712/ 2012-06-07T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-generic-requip-xl-tablets-in-us-080612/ 2012-06-08T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gsk-xenoport-postherpetic-neuralgia-therapy-080612/ 2012-06-08T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-to-offer-larch-arabinogalactan-for-immune-health-080612/ 2012-06-08T02:17:00+00:00 https://www.pharmaceutical-business-review.com/news/particle-sciences-expands-cgmp-capabilities-080612/ 2012-06-08T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/superior-labs-unveils-new-african-mango-diet-supplement-080612/ 2012-06-08T04:23:00+00:00 https://www.pharmaceutical-business-review.com/news/medgenics-opens-new-biopump-processing-facility-in-us-080612/ 2012-06-08T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-initiates-phase-ii-study-of-aln-ttr02-080612/ 2012-06-08T07:51:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-notice-of-allowance-for-coronado-cndo-109-patent-application-080612/ 2012-06-08T07:53:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-teva-reslove-provigil-dispute-110612/ 2012-06-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/crucell-installs-clc-bio-specialized-antibody-engineering-selection-software-110612/ 2012-06-11T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/sectra-takes-over-burnbank-systems-110612/ 2012-06-11T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-status-for-csl-behring-rix-fp-110612/ 2012-06-11T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-launches-dificlir-in-europe-110612/ 2012-06-11T03:08:00+00:00 https://www.pharmaceutical-business-review.com/news/biodel-aegis-sign-licensing-agreement-for-protek-intravail-technologies-110612/ 2012-06-11T03:12:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-incyte-baricitinib-meets-primary-end-point-in-phase-iib-study-110612/ 2012-06-11T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/enwave-signs-new-royalty-bearing-commercial-license-agrrement-110612/ 2012-06-11T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-gets-fda-approval-for-perjeta-110612/ 2012-06-11T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-dako-herceptest-and-her2-fish-pharmdx-kit-120612/ 2012-06-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharm-olam-chooses-datatrak-one-120612/ 2012-06-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/knome-to-begin-early-access-program-for-knomeclinic-140612/ 2012-06-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/protalix-gains-25m-milestone-payment-from-pfizer-120612/ 2012-06-12T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-evolve-trial-fails-to-meet-primary-endpoint-120612/ 2012-06-12T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/almac-vtu-technology-alliance-offer-integrated-service-platform-120612/ 2012-06-12T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/avid-bioservices-to-offer-bacteriophage-production-system-120612/ 2012-06-12T02:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fundacion-medina-cubist-sign-contract-research-collaboration-120612/ 2012-06-12T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-introduces-antihypertensive-franchise-olmesartan-medoxomil-in-mexico-120612/ 2012-06-12T06:57:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-avanir-ind-for-avp-923-study-120612/ 2012-06-12T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-immunetics-bactx-test-130612/ 2012-06-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/tokai-receives-fda-fast-track-designation-for-galeterone-130612/ 2012-06-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ubichem-acquires-new-manufacturing-site-in-hungary-130612/ 2012-06-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-dndi-to-enter-into-neglected-tropical-disease-research-collaboration-130612/ 2012-06-13T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/stiefel-basilea-sign-agreement-for-toctino-120612/ 2012-06-13T02:04:00+00:00 https://www.pharmaceutical-business-review.com/news/adventrx-pierre-sign-manufacturing-contract-for-anx-188-active-ingredient-130612/ 2012-06-13T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/bioinvent-crt-and-queen-mary-enter-into-oncology-collaboration-130612/ 2012-06-13T02:51:00+00:00 https://www.pharmaceutical-business-review.com/news/biologicsmd-enters-into-manufacturing-contract-with-cytovance-130612/ 2012-06-13T05:29:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-announces-positive-study-results-for-dha-during-pregnancy-and-infancy-130612/ 2012-06-13T05:31:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/polyphor-boehringer-enter-into-macrofinder-technology-agreement-130612/ 2012-06-13T05:39:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-takes-over-more-than-99-of-mn-pharmaceuticals-shares-130612/ 2012-06-13T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/genzyme-seeks-approval-for-lemtrada-in-us-europe-130612/ 2012-06-13T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-committee-recommends-orphan-drug-status-for-erytech-product-140612/ 2012-06-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/linguamatics-introduces-i2e-text-mining-solution-140612/ 2012-06-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bioblocks-full-spectrum-to-develop-new-small-molecule-therapeutics-140612/ 2012-06-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/jdrf-novo-nordisk-collaborate-on-type-1-diabet-140612/ 2012-06-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-norge-uses-cegedim-mobile-intelligence-130612/ 2012-06-13T21:42:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-teva-sign-licensing-agreement-for-sitavig-in-israel-140612/ 2012-06-14T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-expands-partnership-with-chinese-drug-manufacturing-company-140612/ 2012-06-14T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-raptor-nda-for-cysteamine-bitartrate-delayed-release-capsules-140612/ 2012-06-14T01:56:00+00:00 https://www.pharmaceutical-business-review.com/news/abl-to-perform-process-development-cgmp-manufacturing-of-scupa-140612/ 2012-06-14T02:20:00+00:00 https://www.pharmaceutical-business-review.com/news/summit-corp-achieves-milestones-in-smt-c1100-phase-1-140612/ 2012-06-14T03:44:00+00:00 https://www.pharmaceutical-business-review.com/news/stratatech-skin-substitute-receives-fda-orphan-drug-status-140612/ 2012-06-14T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/lundbeck-canada-phase-2-alzheimers-disease-study-meets-primary-cognition-endpoint-160512/ 2012-06-14T08:01:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-chemdiv-end-first-phase-of-collaborative-discovery-chemistry-program-140612/ 2012-06-14T08:47:00+00:00 https://www.pharmaceutical-business-review.com/news/five-primebiowa-and-lonza-agree-on-use-of-potelligent-chok1sv-150612/ 2012-06-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gsk-menhibrix-vaccine-150612/ 2012-06-15T01:02:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eli-lilly-to-launch-diabetes-drug-in-india-150612/ 2012-06-15T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-introduces-analgesic-anti-inflammatory-medication-150612/ 2012-06-15T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/innovimmune-receives-grant-to-develop-of-mif-inhibitors-150612/ 2012-06-15T01:36:00+00:00 https://www.pharmaceutical-business-review.com/news/simulations-plus-signs-collaboration-agreement-for-oral-cavity-dosing-model-150612/ 2012-06-15T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-gala-study-of-glatiramer-acetate-injection-meets-primary-endpoint-150612/ 2012-06-15T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/azaya-announces-ati-1123-phase-i-study-results-150612/ 2012-06-15T04:33:00+00:00 https://www.pharmaceutical-business-review.com/news/theraclone-begins-phase-1-dose-escalation-trial-of-tcn-202-150612/ 2012-06-15T07:19:00+00:00 https://www.pharmaceutical-business-review.com/news/biostar-signs-loi-with-chinas-military-medical-varsity-for-viacom-trials-150612/ 2012-06-15T07:22:00+00:00 https://www.pharmaceutical-business-review.com/news/amcor-rychiger-launch-new-packaging-design-for-healthcare-products-150612/ 2012-06-15T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmathene-declares-development-progress-to-sparvax-vaccine/ 2012-06-15T07:30:00+00:00 https://www.pharmaceutical-business-review.com/news/clarity-pharmaceuticals-dalton-pharma-sign-manufacturing-services-contract-150612/ 2012-06-15T08:13:00+00:00 https://www.pharmaceutical-business-review.com/news/quest-pharmatech-to-start-phase-ii-oregovomab-clinical-trial-150612/ 2012-06-15T08:38:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-receives-additional-marketing-application-for-janssen-zytiga-180612/ 2012-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/civitas-launches-phase-2a-clinical-study-of-cvt-301-180612/ 2012-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/valeant-pharmaceuticals-to-acquire-orapharma-180612/ 2012-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ips-academia-life-technologies-sign-ips-cell-patent-portfolio-agreement-180612/ 2012-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-makes-additional-investments-in-china-180612/ 2012-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/raptor-completes-patient-enrollment-for-phase-23-clinical-trial-of-rp103-180612/ 2012-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-begins-market-analysis-for-new-line-of-supplements-for-seniors-180612/ 2012-06-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/us-court-rules-against-merck-in-nasonex-patent-litigation-180612/ 2012-06-18T00:53:00+00:00 https://www.pharmaceutical-business-review.com/news/biocision-to-offer-new-coolbox-xt-technology-180612/ 2012-06-18T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/dyax-reports-interim-analysis-data-of-phase-2-ecallantide-trial-180612/ 2012-06-18T04:15:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-completes-new-clean-room-for-viral-based-gmp-manufacturing-projects-180612/ 2012-06-18T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-announces-voluntarily-recall-of-bcg-vaccine-by-sanofi-pasteur-180612/ 2012-06-18T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/xcellerex-launches-new-bag-type-xdr-10-single-use-bioreactor-180612/ 2012-06-18T07:46:00+00:00 https://www.pharmaceutical-business-review.com/news/ambrx-merck-collaborate-to-develop-biologic-drug-conjugates-180612/ 2012-06-18T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/infinity-reports-interim-results-from-phase-2-study-of-saridegib-190612/ 2012-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/horizon-and-mallinckrodt-to-co-promote-duexis-in-us-190612/ 2012-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/zealand-protagonist-to-develop-peptide-drug-190612/ 2012-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/syringes-services-of-vetter-expands-190612/ 2012-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/geisinger-merck-join-forces-to-improve-patient-health-outcomes-190612/ 2012-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bavarian-nordic-gets-us-contract-to-develop-mva-bn-based-vaccines-190612/ 2012-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bardaemergent-biosolutions-to-set-up-development-and-manufacturing-center-190612/ 2012-06-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-unveils-eclinical-platform-to-simplify-clinical-trial-process-190612/ 2012-06-18T21:04:00+00:00 https://www.pharmaceutical-business-review.com/news/one-lambdacelltrend-gmbh-sign-supply-agreement-180612/ 2012-06-19T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/kinemed-signs-biomarker-research-collaboration-with-gsk-190612/ 2012-06-19T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/orexo-edluar-gains-regulatory-approval-in-europe-190612/ 2012-06-19T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/atherotech-offers-galectin-3-testing-services-190612/ 2012-06-19T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/jpo-issues-patent-to-neurogesx-ngx-1998-190612/ 2012-06-19T07:32:00+00:00 https://www.pharmaceutical-business-review.com/news/procter-gamble-unveils-new-over-the-counter-sleep-aid-190612/ 2012-06-19T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/pacific-biosciences-launches-pacbio-rs-software-200612/ 2012-06-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-harvard-extend-research-collaboration-200612/ 2012-06-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-profile-1007-study-meets-primary-endpoint-200612/ 2012-06-20T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/mars-announces-availability-of-cocoavia-supplement-in-vitamin-world-stores-200612/ 2012-06-20T01:16:00+00:00 https://www.pharmaceutical-business-review.com/news/super-supplements-selects-new-marketing-vendor-200612/ 2012-06-20T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/fsanz-warns-against-sports-supplements-containing-toxic-substance-190612/ 2012-06-20T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/d3-pharma-encap-to-advance-plenachol-licensing-program-200612/ 2012-06-20T04:35:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-announces-new-contract-manufacturing-brand-200612/ 2012-06-20T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/grunenthal-horizon-sign-commercialization-contract-for-duexis-in-latin-america-200612/ 2012-06-20T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-issues-commercial-manufacturing-approval-to-cook-pharmica-200612/ 2012-06-20T07:31:00+00:00 https://www.pharmaceutical-business-review.com/news/mhra-issues-gmp-compliance-certification-for-cmc-biologics-200612/ 2012-06-20T08:17:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-enters-xd-technology-services-agreement-190612/ 2012-06-20T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-venezuela-set-to-market-ranbaxy-products-210612/ 2012-06-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lubrizol-to-take-over-lipotec-210612/ 2012-06-20T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-life-pharmaceuticals-releases-male-enhancement-supplement-210612/ 2012-06-21T00:17:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-takes-over-ardea-biosciences-210612/ 2012-06-21T01:10:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-rigel-sign-license-agreement-for-asthma-therapy-210612/ 2012-06-21T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/illumina-offers-rapidtrack-whole-genome-sequencing-service-210612/ 2012-06-21T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/intermune-completes-sale-of-actimmune-210612/ 2012-06-21T02:06:00+00:00 https://www.pharmaceutical-business-review.com/news/pse-releases-gcrystal-solution/ 2012-06-21T02:56:00+00:00 https://www.pharmaceutical-business-review.com/news/accelrys-unveils-modeling-and-simulation-software/ 2012-06-21T03:03:00+00:00 https://www.pharmaceutical-business-review.com/news/regenerx-dry-eye-therapy-improves-signs-symptoms-in-phase-2-study-210612/ 2012-06-21T03:18:00+00:00 https://www.pharmaceutical-business-review.com/news/acelrx-wins-us-patent-for-sufentanil-nanotab-based-products-210612/ 2012-06-21T05:37:00+00:00 https://www.pharmaceutical-business-review.com/news/liquidia-begins-multi-year-collaboration-with-gsk-210612/ 2012-06-21T05:42:00+00:00 https://www.pharmaceutical-business-review.com/news/west-pharmaceutical-amgen-to-appraise-daikyo-crystal-zenith-technologies-210612/ 2012-06-21T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/shasun-pharma-to-build-intermediates-facility-200612/ 2012-06-21T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/sartorius-bosch-in-single-use-filling-solutions-development-agreement-210612/ 2012-06-21T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/japanese-pharmaceutical-company-chooses-instem-preclinical-software-solution-220612/ 2012-06-21T19:24:00+00:00 https://www.pharmaceutical-business-review.com/news/depomed-gains-rights-to-zipsor-from-xanodyne-220612/ 2012-06-22T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-introduces-generic-equivalent-to-symbyax-in-us-220612/ 2012-06-22T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-pfizer-lyrica-for-neuropathic-pain-management-220612/ 2012-06-22T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/therapeuticsmd-files-additional-patent-applications-for-formulation-technologies-220612/ 2012-06-22T01:13:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-emory-sign-master-clinical-trial-agreement-220612/ 2012-06-22T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/novo-nordisk-to-advance-diabetes-drug-candidate-into-phase-3-development-220612/ 2012-06-22T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/aeterna-perifosine-demonstrates-anti-neuroblastoma-activity-in-phase-1-trial-220612/ 2012-06-22T08:18:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-introduces-generic-exelon-capsules-220612/ 2012-06-22T08:24:00+00:00 https://www.pharmaceutical-business-review.com/news/zeavision-launches-new-eyepromise-eye-vitamin-220612/ 2012-06-22T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/unimark-to-develop-an-antibiotic-api-250612/ 2012-06-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/seebri-breezhaler-gets-positive-chmp-opinion-to-treat-copd-patients-250612/ 2012-06-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genkyotex-reports-positive-data-of-nox-inhibitor-gkt137831-study-250612/ 2012-06-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ntp-deploys-dotmatics-informatics-platform-250612/ 2012-06-24T23:31:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-reports-positive-results-from-phase-iii-cleopatra-study/ 2012-06-25T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-to-advance-clinical-trials-on-kevetrin-250612/ 2012-06-25T01:58:00+00:00 https://www.pharmaceutical-business-review.com/news/us-court-rules-in-tevas-favor-in-copaxone-patent-litigation-250612/ 2012-06-25T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/octagon-introduces-new-startingpoint-document-authoring-solution-250612/ 2012-06-25T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/amag-wins-european-marketing-authorization-for-intravenous-iron-therapy-250612/ 2012-06-25T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-gains-positive-chmp-opinion-for-short-bowel-syndrome-therapy-250612/ 2012-06-25T04:07:00+00:00 https://www.pharmaceutical-business-review.com/news/moberg-ana-darou-sign-naloxemtrix-distribution-agreement-in-iran-250612/ 2012-06-25T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/boston-completes-enrolment-in-phase-ll-trial-of-paz320-250612/ 2012-06-25T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/nih-sbir-funds-sirna-therapeutics-development-260612/ 2012-06-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-gammagard-liquid-to-treat-mmn-260612/ 2012-06-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/slp-to-add-transdermal-subcutaneous-dosing-model-in-gastroplus-260612/ 2012-06-26T00:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-daiichi-sankyo-pennsylvania-packaging-facility-260612/ 2012-06-26T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-launches-hyperphosphatemia-medication-in-japan-260612/ 2012-06-26T02:28:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-bend-to-provide-integrated-solutions-for-pharma-firms-250612/ 2012-06-26T02:43:00+00:00 https://www.pharmaceutical-business-review.com/news/divine-skin-to-start-production-of-new-otc-analgesic-260612/ 2012-06-26T03:05:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-unveils-new-probiotic-dietary-supplement-260612/ 2012-06-26T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/amderma-oculus-to-develop-microcyn-based-drugs-260612/ 2012-06-26T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-actavis-generic-adderall-xr-cii-260612/ 2012-06-26T05:36:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-to-expand-new-life-naturals-product-line-260612/ 2012-06-26T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/eps-offers-analytical-chemistry-microbiological-services-260612/ 2012-06-26T05:44:00+00:00 https://www.pharmaceutical-business-review.com/news/pathway-genomics-forms-strategic-alliance-with-dasa-260612/ 2012-06-26T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/neuralstem-begins-ib-phase-of-nsi-189-trial-260612/ 2012-06-26T09:03:00+00:00 https://www.pharmaceutical-business-review.com/news/caris-life-sciences-unveils-new-molecular-profiling-service-for-cancer-patients-270612/ 2012-06-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/perkin-elmer-unveils-onesource-scientific-it-services/ 2012-06-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/primeradx-eli-lilly-enter-into-product-development-collaboration-270612/ 2012-06-27T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-submits-maa-to-ema-for-enzalutamide-270612/ 2012-06-27T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/impax-tolmar-sign-development-distribution-agreement-270612/ 2012-06-27T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/ferrer-withdraws-egrifta-marketing-authorisation-application-in-europe-270612/ 2012-06-27T02:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-dynavax-heplisav-bla-270612/ 2012-06-27T02:44:00+00:00 https://www.pharmaceutical-business-review.com/news/gedeon-richter-selects-psion-omnii-xt15-terminals-270612/ 2012-06-27T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/quotient-capsugel-partner-to-address-drug-delivery-challenges-of-poorly-soluble-molecules-260612/ 2012-06-27T05:01:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-serono-compugen-to-set-up-new-biomarker-company-270612/ 2012-06-27T06:25:00+00:00 https://www.pharmaceutical-business-review.com/news/sfda-grants-manufacturing-approval-for-shandong-human-coagulation-fviii-270612/ 2012-06-27T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/adventrx-patheon-sign-anx-188-drug-manufacturing-agreement-270612/ 2012-06-27T07:17:00+00:00 https://www.pharmaceutical-business-review.com/news/tocagen-forms-strategic-alliance-with-mri-interventions-brainlab-270612/ 2012-06-27T08:09:00+00:00 https://www.pharmaceutical-business-review.com/news/cornerstone-buys-ekr-therapeutics-280612/ 2012-06-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biodiem-anu-sign-dengue-fever-vaccine-technology-agreement-280612/ 2012-06-27T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/arena-eisai-obesity-drug-receives-fda-approval-280612/ 2012-06-28T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/biodiem-university-of-canberra-sign-licensing-agreement-for-hepatitis-vaccine-technology-280612/ 2012-06-28T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/albemarle-upgrades-michigan-production-site-280612/ 2012-06-28T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-perrigo-anda-for-generic-duac-gel-280612/ 2012-06-28T01:24:00+00:00 https://www.pharmaceutical-business-review.com/news/idri-soligenix-partner-to-develop-biodefense-vaccines-280612/ 2012-06-28T04:01:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-uk-announces-availability-of-generic-bonviva-280612/ 2012-06-28T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-sciences-seeks-marketing-approval-for-elvitegravir-280612/ 2012-06-28T05:33:00+00:00 https://www.pharmaceutical-business-review.com/news/kinemed-wins-12m-grant-to-advance-brain-process-biomarker-research-280612/ 2012-06-28T05:35:00+00:00 https://www.pharmaceutical-business-review.com/news/protaffin-initiates-phase-1-study-of-anti-inflammatory-product-280612/ 2012-06-28T05:38:00+00:00 https://www.pharmaceutical-business-review.com/news/sartorius-opens-new-biopharmaceutical-production-facility-in-us-280612/ 2012-06-28T05:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-bayer-regorafenib-nda-280612/ 2012-06-28T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-sued-for-pristiq-tablets-patent-290612/ 2012-06-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pure-matters-unveils-three-new-health-supplements-290612/ 2012-06-28T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-anda-for-thiamine-hydrochloride-injection-290612/ 2012-06-29T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/yakult-begins-phase-1-multiple-myeloma-trial-with-perifosine-290612/ 2012-06-29T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-wins-fda-approval-for-overactive-bladder-therapy-290612/ 2012-06-29T01:01:00+00:00 https://www.pharmaceutical-business-review.com/news/bedford-recalls-vecuronium-bromide-for-injection-at-hospitaluser-level-290612/ 2012-06-29T02:48:00+00:00 https://www.pharmaceutical-business-review.com/news/sfda-approves-3sbios-application-for-china-arm-of-phase-iii-voclosporin-trial-290612/ 2012-06-29T02:50:00+00:00 https://www.pharmaceutical-business-review.com/news/merrimack-expands-phase-3-napoli-1-study-290612/ 2012-06-29T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/abaxis-to-deliver-piccolo-xpress-analyzers-for-four-year-drug-trial-290612/ 2012-06-29T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-actelion-snda-for-second-generation-veletri-for-injection-290612/ 2012-06-29T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/goldman-sachs-announces-investment-in-orchid-chemicals-290612/ 2012-06-29T06:48:00+00:00 https://www.pharmaceutical-business-review.com/news/medivir-to-begin-interferon-free-combination-study-with-tmc435-daclatasvir-290612/ 2012-06-29T06:51:00+00:00 https://www.pharmaceutical-business-review.com/news/millennium-commences-phase-3-trial-of-mln9708-290612/ 2012-06-29T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-approves-astellas-prostate-cancer-drug-020712/ 2012-07-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-to-take-over-amylin-pharmaceuticals-020712/ 2012-07-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-and-isis-sign-deal-to-develop-antisense-drug-for-steinert-disease-020712/ 2012-07-02T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/canadian-patent-protects-use-of-lorus-cancer-immunotherapy-agent-020712/ 2012-07-02T02:18:00+00:00 https://www.pharmaceutical-business-review.com/news/mitsubishi-tanabe-receives-approval-for-tenelia-20mg-tablets-in-japan-020712/ 2012-07-02T02:22:00+00:00 https://www.pharmaceutical-business-review.com/news/ap-pharma-announces-patient-satisfaction-data-from-phase-3-cinv-study-020712/ 2012-07-02T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-ibandronate-sodium-tablets-in-us-020712/ 2012-07-02T05:32:00+00:00 https://www.pharmaceutical-business-review.com/news/teijin-gains-manufacturing-marketing-approval-for-somatuline-in-japan/ 2012-07-02T05:34:00+00:00 https://www.pharmaceutical-business-review.com/news/scinopharm-to-construct-high-potency-cytotoxic-injectable-plant-facility-020712/ 2012-07-02T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/sosei-completes-phase-i-study-of-so-1105-020712/ 2012-07-02T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-seeks-fda-approval-for-bedaquiline-drug-to-treat-tuberculosis-030712/ 2012-07-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/indian-pharma-firm-defers-rwanda-manufacturing-plant-030712/ 2012-07-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/study-says-otc-nsaids-do-not-cause-miscarriage-100712/ 2012-07-02T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicomm-larix-partner-for-eclinical-solutions-030712/ 2012-07-02T20:08:00+00:00 https://www.pharmaceutical-business-review.com/news/new-ppp-to-develop-pediatric-formulation-to-treat-schistosomiasis-030712/ 2012-07-03T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-expands-xs-technology-toolbox-030612/ 2012-07-03T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-pay-3bn-plead-guilty-for-promoting-antidepressants-030712/ 2012-07-03T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-roche-hiv-viral-load-test-030712/ 2012-07-03T04:47:00+00:00 https://www.pharmaceutical-business-review.com/news/prophase-unveils-cold-eeze-cold-remedy-daytimenighttime-quickmelt-tablets-030712/ 2012-07-03T04:51:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-notice-of-allowance-for-avanir-nuedexta-patent-030712/ 2012-07-03T06:32:00+00:00 https://www.pharmaceutical-business-review.com/news/cerulean-begins-phase-1b2a-study-of-crlx101-030712/ 2012-07-03T06:34:00+00:00 https://www.pharmaceutical-business-review.com/news/onyx-commences-phase-3-relapsed-multiple-myeloma-trial-030712/ 2012-07-03T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/diamyd-phase-ii-cancer-pain-study-fails-to-meet-primary-objective-030712/ 2012-07-03T09:05:00+00:00 https://www.pharmaceutical-business-review.com/news/european-community-funds-dyadic-to-develop-enzymes-030712/ 2012-07-03T09:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-cornerstones-anda-for-gneric-tussionex-pennkinetic-product-030712/ 2012-07-03T09:10:00+00:00 https://www.pharmaceutical-business-review.com/news/herberex-provides-male-enhancement-supplement-private-label-services-030712/ 2012-07-03T09:13:00+00:00 https://www.pharmaceutical-business-review.com/news/alvogen-to-distribute-probi-gut-immune-health-products-in-taiwan-040712/ 2012-07-04T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/dbm-wins-fund-from-nccam-for-metabolic-diseases-drug-discovery-program-040712/ 2012-07-04T00:32:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-orasure-otc-hiv-test-kit-040712/ 2012-07-04T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-cellworks-partner-to-develop-tuberculosis-combination-therapies-040712/ 2012-07-04T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/tufts-medical-center-wins-10m-grant-to-advance-blood-clot-prevention-drug-040712/ 2012-07-04T01:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ferring-albireo-sign-licensing-agreement-for-elobixibat-040712/ 2012-07-04T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/ampio-signs-zertane-ed-manufacturing-contract-with-syngene-040712/ 2012-07-04T05:46:00+00:00 https://www.pharmaceutical-business-review.com/news/bit-analytical-drg-diagnostics-to-unveil-new-hybrid-analyzer-040712/ 2012-07-04T05:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-anda-for-lithium-carbonate-extended-release-tablets-040712/ 2012-07-04T05:52:00+00:00 https://www.pharmaceutical-business-review.com/news/lupin-wins-fda-approval-for-norgestimate-and-ethinyl-estradiol-tablets-040712/ 2012-07-04T05:54:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-therapeutics-to-buy-great-southern-laboratories-040712/ 2012-07-04T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/spectrum-begins-phase-2-glioblastoma-multiforme-study-050712/ 2012-07-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mda-receives-funds-to-upgrade-advanced-technology-solution-050712/ 2012-07-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mcc-of-south-africa-selects-extedo-solution-for-eres-project-050712/ 2012-07-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/thermogenesis-divests-cryoseal-fibrin-sealant-system-wound-care-product-line-050712/ 2012-07-04T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bedford-recalls-leucovorin-calcium-injection-at-hospitaluser-level-050712/ 2012-07-05T00:15:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-generic-clarinex-tablets-050712/ 2012-07-05T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/thrombogenics-ocriplasmin-intravitreal-injection-gains-fda-priority-review-050712/ 2012-07-05T00:26:00+00:00 https://www.pharmaceutical-business-review.com/news/anges-mitsubishi-sign-deal-for-collategene-marketing-rights-in-us-050712/ 2012-07-05T00:29:00+00:00 https://www.pharmaceutical-business-review.com/news/genstar-capital-takes-over-ert-050712/ 2012-07-05T01:52:00+00:00 https://www.pharmaceutical-business-review.com/news/nps-amends-cinacalcet-hcl-license-agreement-with-amgen-050712/ 2012-07-05T01:54:00+00:00 https://www.pharmaceutical-business-review.com/news/jj-recalls-vaginal-lubricant-050712/ 2012-07-05T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-receives-european-patent-covering-for-inno-206-linker-technology-050712/ 2012-07-05T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-therapeutics-announces-validation-performance-of-ctx-294886-060712/ 2012-07-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pharming-phase-iii-ruconest-study-reaches-full-recruitment-060712/ 2012-07-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-biovitrum-initiate-two-trials-of-hemophilia-a-and-b-candidates-in-children-060712/ 2012-07-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-notice-of-allowance-for-amarin-patent-covering-amr101-060712/ 2012-07-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/siegfried-to-build-new-production-plant-in-china-050712/ 2012-07-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/brenntag-to-buy-specialty-chemical-distributor-050712/ 2012-07-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-lupin-generic-lyrica-capsules-060712/ 2012-07-06T05:47:00+00:00 https://www.pharmaceutical-business-review.com/news/medunik-to-distribute-orphan-rare-diseases-therapies-in-canada-060712/ 2012-07-06T05:48:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-grants-satrx-exclusive-license-to-dpp-ivi-type-2-diabetes-candidate-060712/ 2012-07-06T05:51:00+00:00 https://www.pharmaceutical-business-review.com/news/prosonix-imperial-college-to-accelerate-multi-component-particles-development-060712/ 2012-07-06T05:55:00+00:00 https://www.pharmaceutical-business-review.com/news/renaissance-acquisition-holdings-takes-over-dpt-laboratories-060712/ 2012-07-06T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/sucampo-receives-approval-for-amitiza-in-japan-060712/ 2012-07-06T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/amgen-acquires-kai-pharmaceutical-060712/ 2012-07-06T08:48:00+00:00 https://www.pharmaceutical-business-review.com/news/cancer-research-technology-adc-therapeutics-to-develop-cancer-treatment-060712/ 2012-07-06T08:59:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-commences-phase-iii-trial-of-hemophilia-drug-090712/ 2012-07-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pds-biotechnology-merck-kgaa-sign-versamune-technology-agreement-090712/ 2012-07-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gateway-to-begin-phase-ii-cancer-study-090612/ 2012-07-08T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/r-tech-ueno-announces-arbitration-result-against-takeda-pharma-090712/ 2012-07-09T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-meets-fda-norms-for-pediatric-exclusivity-for-cymbalta-090712/ 2012-07-09T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/bioanalytical-systems-names-new-president-and-ceo-090712/ 2012-07-09T03:14:00+00:00 https://www.pharmaceutical-business-review.com/news/shangpharma-confirms-receipt-of-proposal-for-going-private-090712/ 2012-07-09T03:17:00+00:00 https://www.pharmaceutical-business-review.com/news/sobi-files-kineret-application-with-fda-for-nomid-indication-090712/ 2012-07-09T03:19:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-receives-fda-approval-for-erbitux-use-in-kras-wild-type-cancer-090712/ 2012-07-09T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/excellere-sells-mts-technologies-100712/ 2012-07-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dietary-supplements-boost-nutrition-levels-in-children-study100712/ 2012-07-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-licenses-insulin-producing-beta-cells-to-janseen-100712/ 2012-07-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/saladax-therapeutic-dose-management-assays-win-ce-mark-100712/ 2012-07-09T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/barts-health-nhs-trust-selects-hylands-ecm-solution-100712/ 2012-07-09T19:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fujifilm-wins-onc-atcb-20112012-certification-for-synapse-mu-30-100712/ 2012-07-09T20:00:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-cdri-to-launch-rd-projects-in-russia-100712/ 2012-07-10T01:23:00+00:00 https://www.pharmaceutical-business-review.com/news/eisai-reports-preliminary-results-from-phase-iii-study-of-halaven-100712/ 2012-07-10T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-issues-allowance-for-cytrx-patent-application-for-tamibarotene-capsule-100712/ 2012-07-10T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/sedona-recalls-iflora-kids-multi-probiotic-iflora-4-kids-powder-dietary-supplements-100712/ 2012-07-10T06:39:00+00:00 https://www.pharmaceutical-business-review.com/news/tonix-reports-positive-animal-pk-study-data-of-sl-tnx-102-100712/ 2012-07-10T06:46:00+00:00 https://www.pharmaceutical-business-review.com/news/health-canada-approves-auxilium-xiaflex-to-treat-dupuytrens-contracture-100712/ 2012-07-10T07:10:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-applauds-drug-safety-and-innovation-act-launch100712/ 2012-07-10T07:14:00+00:00 https://www.pharmaceutical-business-review.com/news/sanovel-plans-to-export-breathing-apparatuses-to-europe/ 2012-07-10T07:21:00+00:00 https://www.pharmaceutical-business-review.com/news/youngevity-to-begin-clinical-research-studies-at-clemson-university-100712/ 2012-07-10T07:24:00+00:00 https://www.pharmaceutical-business-review.com/news/mobius-begins-commercial-shipment-of-mitosol-kit-100712/ 2012-07-10T08:21:00+00:00 https://www.pharmaceutical-business-review.com/news/unilife-wins-us-patent-for-prefilled-syringe-110712/ 2012-07-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genisphere-limr-to-continue-studies-on-bowel-disorders-110712/ 2012-07-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/titan-completes-dopamine-agonist-preclinical-study-110712/ 2012-07-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/aptalis-sponsors-2012-controlled-release-societys-young-investigator-award-260712/ 2012-07-10T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/galenea-eisai-sign-strategic-neuroscience-collaboration-110712/ 2012-07-11T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/tjl-enterprises-announces-availability-of-homeopathic-gripe-water-in-us-110712/ 2012-07-11T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/oculus-gains-approval-for-microcyn-hydrogel-in-china-110712/ 2012-07-11T01:20:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-notice-of-allowance-for-star-scientific-claims-covering-anatabine-110712/ 2012-07-11T01:33:00+00:00 https://www.pharmaceutical-business-review.com/news/cylene-announces-evidence-for-targeting-of-pol-i-as-new-approach-to-cancer-therapy-110712/ 2012-07-11T02:02:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-xenoport-announces-availability-of-rls-drug-in-japan-110712/ 2012-07-11T02:36:00+00:00 https://www.pharmaceutical-business-review.com/news/ebd-group-enters-into-strategic-alliance-with-inova-software-110712/ 2012-07-11T02:38:00+00:00 https://www.pharmaceutical-business-review.com/news/kaluga-government-considers-establishing-pharmaceutical-manufacturing-hub-110712/ 2012-07-11T02:53:00+00:00 https://www.pharmaceutical-business-review.com/news/ablexis-announces-new-license-agreement-for-alivamab-mouse-technology-110712/ 2012-07-11T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-multistem-hurlers-syndrome-therapy-110712/ 2012-07-11T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/pernix-introduces-triple-combination-oral-therapy-to-treat-h-pylori-infection-110712/ 2012-07-11T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/ap-pharma-new-drug-delivery-candidate-wins-us-patent-110712/ 2012-07-11T08:05:00+00:00 https://www.pharmaceutical-business-review.com/news/sobiaffibody-collaborate-on-inflammatory-diseases-treatments-120712/ 2012-07-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-harvard-university-team-up-for-unmet-medical-needs-120712/ 2012-07-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-releases-data-on-albiglutide-clinical-programme-120712/ 2012-07-11T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abbott-launches-new-laboratory-informatics-solution-120712/ 2012-07-11T23:10:00+00:00 https://www.pharmaceutical-business-review.com/news/perkinelmer-launches-ensemble-for-qaqc-integrated-informatics-solution-120712/ 2012-07-12T00:27:00+00:00 https://www.pharmaceutical-business-review.com/news/gerresheimer-to-expand-production-capacity-of-czech-plant-120712/ 2012-07-12T01:17:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-wins-fda-approval-for-generic-arthrotec-120712/ 2012-07-12T01:19:00+00:00 https://www.pharmaceutical-business-review.com/news/medikly-launches-konnect-analytics-platform-120712/ 2012-07-12T02:16:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-pomaglumetad-methionil-fails-to-meet-primary-endpoint-in-hbbm-study-120712/ 2012-07-12T02:25:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-recalls-robitussin-dm-product-due-to-labeling-errors-120712/ 2012-07-12T04:34:00+00:00 https://www.pharmaceutical-business-review.com/news/scolr-pharma-oral-ibuprofen-wins-european-patent-120712/ 2012-07-12T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/raybiotech-unveils-peptoid-based-drug-discovery-services-120712/ 2012-07-12T06:44:00+00:00 https://www.pharmaceutical-business-review.com/news/immunogen-begins-phase-i-cancer-trial-of-imgn853-120712/ 2012-07-12T07:41:00+00:00 https://www.pharmaceutical-business-review.com/news/merus-labs-acquires-emselexenablex-drug-rights-in-canada-europe-120712/ 2012-07-12T07:44:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-plans-expansion-in-us-130712/ 2012-07-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gentris-expands-pharmacogenomics-services-160712/ 2012-07-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/jubilant-selects-emerson-process-automation-technologies-services-130712/ 2012-07-12T23:59:00+00:00 https://www.pharmaceutical-business-review.com/news/verastem-eisai-sign-research-collaboration-for-small-molecule-wnt-inhibitors-130712/ 2012-07-13T00:02:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-unveils-new-gs-xceed-gene-expression-system-130712/ 2012-07-13T00:19:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-signs-omontys-injection-supply-contract-with-fresenius-130712/ 2012-07-13T00:43:00+00:00 https://www.pharmaceutical-business-review.com/news/zogenix-commences-first-ind-clinical-trial-for-relday-130712/ 2012-07-13T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-ascletis-to-develop-hcc-rnai-therapeutic-130712/ 2012-07-13T02:46:00+00:00 https://www.pharmaceutical-business-review.com/news/celgene-psoriatic-arthritis-drug-meets-primary-endpoint-130712/ 2012-07-13T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/vertellus-olt-in-logistics-service-expansion-agreement-130712/ 2012-07-13T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/cubist-pharmaceuticals-begins-cdad-trials-160712/ 2012-07-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-seeks-court-injection-against-kabco-pharmaceuticals-170712/ 2012-07-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/chpa-applauds-introduction-of-pact-legislation-170712/ 2012-07-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-allscripts-to-develop-new-software-solutions-for-clinical-research-160712/ 2012-07-15T23:18:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-theravance-seek-approvals-for-ffvi-in-us-europe-160712/ 2012-07-16T01:12:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-wins-fda-approval-for-progestin-only-emergency-contraceptive-160712/ 2012-07-16T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/medistem-announces-initiation-of-critical-limb-ischemia-study-160712/ 2012-07-16T03:51:00+00:00 https://www.pharmaceutical-business-review.com/news/tris-pharma-completes-first-phase-of-manufacturing-expansion-160712/ 2012-07-16T03:56:00+00:00 https://www.pharmaceutical-business-review.com/news/aarti-industries-to-merge-with-anushakti-manufacturing-division-160712/ 2012-07-16T04:41:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-recalls-cancer-drugs-packaged-in-vials-160712/ 2012-07-16T06:15:00+00:00 https://www.pharmaceutical-business-review.com/news/vitalah-introduces-new-oxylent-nutritional-supplement-formulation-160712/ 2012-07-16T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/addex-reports-positive-pre-clinical-efficacy-data-of-adx88178-in-parkinsons-disease-study-160712/ 2012-07-16T08:02:00+00:00 https://www.pharmaceutical-business-review.com/news/rs-medical-to-distribute-harvest-terumo-platelet-concentrate-system-160712/ 2012-07-16T08:08:00+00:00 https://www.pharmaceutical-business-review.com/news/elsevier-enhances-product-literature-solution-160712/ 2012-07-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ucb-unveils-neupro-drug-in-us-market-160712/ 2012-07-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-enhances-drug-process-technology-160712/ 2012-07-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-hiv-drug-wins-fda-approval-170712/ 2012-07-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-pasteur-ships-influenza-virus-vaccine-to-us-170712/ 2012-07-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-submits-simponi-drug-for-us-and-ema-approval-170712/ 2012-07-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cellceutix-prurisol-kevetrin-clinical-trials-move-ahead-170712/ 2012-07-16T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/glaxosmithkline-to-takeover-hgs-170712/ 2012-07-17T00:40:00+00:00 https://www.pharmaceutical-business-review.com/news/evotec-to-offer-rapidfire-mass-spectrometry-analysis-capabilities-170712/ 2012-07-17T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/clovis-array-collaborate-to-discover-mutant-kit-inhibitor-for-gist-170712/ 2012-07-17T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-cplb-icgeb-partner-to-develop-malaria-vaccine-in-india-170712/ 2012-07-17T04:18:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-zogenix-zohydro-er-nda-170712/ 2012-07-17T04:40:00+00:00 https://www.pharmaceutical-business-review.com/news/vitalmax-develops-new-immune-system-supplement-170712/ 2012-07-17T05:58:00+00:00 https://www.pharmaceutical-business-review.com/news/peregrine-begins-investigator-sponsored-trial-with-bavituximab-170712/ 2012-07-17T06:01:00+00:00 https://www.pharmaceutical-business-review.com/news/pct-and-sotio-sign-phase-3-manufacturing-services-agreement-170712/ 2012-07-17T06:10:00+00:00 https://www.pharmaceutical-business-review.com/news/lees-pharma-licenses-regenerx-thymosin-based-products-170712/ 2012-07-17T07:54:00+00:00 https://www.pharmaceutical-business-review.com/news/afraxis-psychogenics-alliance-to-offer-esp-drug-discovery-technology-180712/ 2012-07-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-baxters-hemophilia-treatment-180712/ 2012-07-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-qsymia-obesity-capsule-180712/ 2012-07-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/medpace-to-open-new-ohio-clinical-unit-180712/ 2012-07-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/crmims-health-to-expand-partnership-180712/ 2012-07-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/omnicomm-unveils-new-dynamic-monitoring-functionality-solution-230712/ 2012-07-17T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/amcom-launches-version-50-of-amcom-critical-test-results-management-solution-180712/ 2012-07-17T23:03:00+00:00 https://www.pharmaceutical-business-review.com/news/innophos-takes-over-amt-labs-180712/ 2012-07-18T00:50:00+00:00 https://www.pharmaceutical-business-review.com/news/astrazeneca-to-begin-pad-study-with-ticagrelor-180712/ 2012-07-18T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/biotime-jade-sign-sublicense-agreement-for-hystem-technology-180712/ 2012-07-18T04:26:00+00:00 https://www.pharmaceutical-business-review.com/news/dsm-signs-biologics-contract-manufacturing-agreement-with-recepta-180712/ 2012-07-18T04:28:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-settles-generic-silenor-patent-litigation-with-somaxon-180712/ 2012-07-18T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-amicus-expand-partnership-to-develop-investigational-agent-for-fabry-disease-180712/ 2012-07-18T06:04:00+00:00 https://www.pharmaceutical-business-review.com/news/emmaus-sickle-cell-disease-therapy-gains-european-orphan-product-designation-180712/ 2012-07-18T07:33:00+00:00 https://www.pharmaceutical-business-review.com/news/medpro-signs-license-agreement-for-drug-delivery-platform-180712/ 2012-07-18T07:37:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-launches-new-glucosamine-sulfate-supplement-180712/ 2012-07-18T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/phyton-wins-cep-for-paclitaxel-api-produced-from-plant-cell-fermentation-180712/ 2012-07-18T08:32:00+00:00 https://www.pharmaceutical-business-review.com/news/retrophin-signs-research-agreement-with-st-jude-childrens-hospital-180712/ 2012-07-18T08:37:00+00:00 https://www.pharmaceutical-business-review.com/news/scinopharm-to-provide-topiramate-api-for-vivus-anti-obesity-drug-230712/ 2012-07-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/premama-introduces-prenatal-supplement-drink-mix-230712/ 2012-07-18T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dr-reddys-introduces-generic-anti-cholesterol-drug-in-us-190712/ 2012-07-19T00:44:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-signs-research-license-agreement-for-ranibizumab-190712/ 2012-07-19T00:58:00+00:00 https://www.pharmaceutical-business-review.com/news/galena-wins-us-patent-for-her2neu-peptide-vaccine-190712/ 2012-07-19T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/psivida-receives-iluvien-marketing-authorization-in-france-190712/ 2012-07-19T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/novavax-path-sign-rsv-vaccine-clinical-development-partnership-190712/ 2012-07-19T03:47:00+00:00 https://www.pharmaceutical-business-review.com/news/angion-doses-first-patient-in-phase-ii-heart-attack-trial-190712/ 2012-07-19T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-idec-enters-into-als-research-collaboration-agreement-190712/ 2012-07-19T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/sanofi-enters-into-diabetes-research-collaboration-with-bwh-190712/ 2012-07-19T06:08:00+00:00 https://www.pharmaceutical-business-review.com/news/nathealth-introduces-new-cardiovascular-health-supplement-190712/ 2012-07-19T06:29:00+00:00 https://www.pharmaceutical-business-review.com/news/prometheus-grants-oncology-program-to-clinipace-200712/ 2012-07-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/battelle-receives-niaid-biodefense-research-contract-020712/ 2012-07-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/csd-intrinsiq-unveil-integrated-oncology-data-solution-200712/ 2012-07-19T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ema-to-review-pfizer-maa-for-bazedoxifeneconjugated-estrogens-200712/ 2012-07-20T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-kddf-partner-to-step-up-drug-development-commercialization-200712/ 2012-07-20T00:56:00+00:00 https://www.pharmaceutical-business-review.com/news/acucela-otsuka-begin-phase-3-dry-eye-syndrome-trial-200712/ 2012-07-20T01:26:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-reports-phase-iii-brisk-fl-trial-results-200712/ 2012-07-20T04:22:00+00:00 https://www.pharmaceutical-business-review.com/news/medica-unveils-easycell-assistant-cell-image-analyzer-200712/ 2012-07-20T04:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sunshine-biopharma-signs-adva-27a-manufacturing-contract-with-beta-pharma-200712/ 2012-07-20T06:59:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-receives-positive-chmp-opinion-for-crizotinib-230712/ 2012-07-23T01:38:00+00:00 https://www.pharmaceutical-business-review.com/news/eli-lilly-kowa-report-pk-study-results-of-drug-interactions-230712/ 2012-07-23T01:42:00+00:00 https://www.pharmaceutical-business-review.com/news/sarepta-marburg-virus-drug-demonstrates-survival-in-nhp-study-230712/ 2012-07-23T01:45:00+00:00 https://www.pharmaceutical-business-review.com/news/mitsubishi-tanabe-introduces-news-dosage-to-antipsychotic-agent-230712/ 2012-07-23T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/onyx-gains-fda-approval-for-kyprolis-for-injection-230712/ 2012-07-23T04:38:00+00:00 https://www.pharmaceutical-business-review.com/news/synergy-callisto-sign-definitive-merger-agreement-230712/ 2012-07-23T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/bayer-onyx-astellas-report-phase-3-hcc-trial-results-230712/ 2012-07-23T06:28:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-novartis-afinitor-to-treat-advanced-breast-cancer-230712/ 2012-07-23T06:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biolife-solutions-expands-corporate-facilities-240712/ 2012-07-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bg-medicine-seeks-fda-clearence-for-architect-galectin-3-assay-240712/ 2012-07-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/adcetris-receives-positive-opinion-from-ema-240712/ 2012-07-23T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sandoz-takesover-fougera-pharmaceuticals-240712/ 2012-07-24T00:51:00+00:00 https://www.pharmaceutical-business-review.com/news/galapagos-identifies-drug-candidate-in-osteoarthritis-alliance-with-servier-240712/ 2012-07-24T01:25:00+00:00 https://www.pharmaceutical-business-review.com/news/pacific-biosciences-imec-partner-to-develop-advanced-microchips-240712/ 2012-07-24T01:29:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-purchases-rights-to-funxionals-fx125l-compound-240712/ 2012-07-24T02:24:00+00:00 https://www.pharmaceutical-business-review.com/news/xenoport-begins-phase-i-trial-of-fumarate-analog-240712/ 2012-07-24T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-lyrica-meets-primary-endpoint-in-phase-4-study-240712/ 2012-07-24T08:19:00+00:00 https://www.pharmaceutical-business-review.com/news/medline-purchases-key-assets-of-perrigo-personal-hygiene-business-240712/ 2012-07-24T08:23:00+00:00 https://www.pharmaceutical-business-review.com/news/galectin-wins-us-patent-for-chronic-liver-disease-therapy-240712/ 2012-07-24T08:25:00+00:00 https://www.pharmaceutical-business-review.com/news/basilea-stiefel-complete-dermatology-drug-transaction-240712/ 2012-07-24T08:42:00+00:00 https://www.pharmaceutical-business-review.com/news/hhs-walgreens-to-develop-mtm-for-hiv-patients-250712/ 2012-07-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/china-botanic-schisandra-lignin-extraction-method-wins-patent-250712/ 2012-07-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/immunomedics-karolinska-institutet-partner-for-anti-hiv-drug-development-250712/ 2012-07-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-rad-myriad-rbm-to-develop-multiplex-biomarker-kits-250712/ 2012-07-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/envirologix-douglas-scientific-combine-to-develop-nucleic-acid-analysis-solutions-250712/ 2012-07-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/dhin-certifies-advanced-data-systems-medicsdocassistant-ehr-300712/ 2012-07-24T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-signs-two-licensing-deals-for-hiv-drug-candidates-250712/ 2012-07-25T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/coldstream-revamps-manufacturing-facility-240712/ 2012-07-25T01:22:00+00:00 https://www.pharmaceutical-business-review.com/news/medicago-completes-milestone-under-technology-investment-agreement-with-darpa-250712/ 2012-07-25T01:55:00+00:00 https://www.pharmaceutical-business-review.com/news/nektar-begins-phase-2-study-of-nktr-181-250712/ 2012-07-25T04:10:00+00:00 https://www.pharmaceutical-business-review.com/news/parexel-introduces-new-delivery-model-250712/ 2012-07-25T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/taiho-signs-license-agreement-for-anti-allergy-product-development-250712/ 2012-07-25T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/suzhou-arena-in-anti-inflammatory-compounds-license-agreement-250712/ 2012-07-25T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/advinus-p2d-sign-adhd-research-collaboration-250712/ 2012-07-25T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/catalent-begins-supply-of-abilify-antipsychotic-drug-to-otsuka-pharma-250712/ 2012-07-25T06:18:00+00:00 https://www.pharmaceutical-business-review.com/news/sagent-launches-oxacillin-for-injection-usp-250712/ 2012-07-25T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/gilead-spirit-study-meets-24-week-primary-endpoint/ 2012-07-25T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/biofocus-to-offer-activiomics-proteomics-services-260712/ 2012-07-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-neurogesx-enroll-first-patient-for-elevate-study-260712/ 2012-07-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/blackstone-invests-125m-in-nantpharma-260712/ 2012-07-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mozambique-opens-brazil-funded-arv-drug-plant-260712/ 2012-07-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/complete-nutrition-launches-3plenish-an-intra-workout-drink-mix-260712/ 2012-07-25T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-wins-fda-priority-review-for-promacta-supplemental-new-drug-application-260712/ 2012-07-26T00:49:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-qualitest-levetiracetam-anda-260712/ 2012-07-26T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/jennerex-begins-phase-2-hcc-trial-of-jx-594-260712/ 2012-07-26T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/cytrx-begins-phase-1b-solid-tumour-trial-260712/ 2012-07-26T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-fast-track-designation-for-idenix-hcv-therapy-260712/ 2012-07-26T04:02:00+00:00 https://www.pharmaceutical-business-review.com/news/fraunhofer-wins-german-manufacturing-certification-for-dcvax-l-therapy-260712/ 2012-07-26T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/karyopharm-doses-patients-in-two-kpt-330-phase-1-trials-260712/ 2012-07-26T04:17:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-eli-lilly-receive-jentadueto-european-marketing-authorization-260712/ 2012-07-26T05:53:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-immunocellular-ind-application-of-phase-i-ict-121-trial-260712/ 2012-07-26T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/fmc-to-build-new-microcrystalline-cellulose-manufacturing-facility-in-thailand-260712/ 2012-07-26T06:56:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-horizon-pharms-rayos-tablet-270712/ 2012-07-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ibio-ge-healthcare-form-patnership-270712/ 2012-07-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ingredion-recalls-dietary-ingredient-270712/ 2012-07-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/philippines-doh-unveil-micronutrient-supplement-for-kids-270712/ 2012-07-26T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/novartis-begins-shipment-of-fluvirin-influenza-seasonal-vaccine-in-us-270712/ 2012-07-27T00:52:00+00:00 https://www.pharmaceutical-business-review.com/news/linde-gases-unveils-new-cryogenic-technology-for-lyophilisation-270712/ 2012-07-27T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/metabolix-signs-loi-with-antibioticos-for-mirel-biopolymer-resin-production-270712/ 2012-07-27T01:47:00+00:00 https://www.pharmaceutical-business-review.com/news/bioalliance-wins-us-patent-for-sitavig-tablet/ 2012-07-27T01:49:00+00:00 https://www.pharmaceutical-business-review.com/news/biodel-wins-sbir-grant-to-develop-concentrated-ultra-rapid-acting-insulin-formulations-270712/ 2012-07-27T04:03:00+00:00 https://www.pharmaceutical-business-review.com/news/protalex-reports-phase-1b-prtx-100-dose-escalation-study-data-270712/ 2012-07-27T04:31:00+00:00 https://www.pharmaceutical-business-review.com/news/viropharma-announces-positive-results-for-cinryze-study-300712/ 2012-07-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-submits-its-ndas-for-us-fda-review-300712/ 2012-07-29T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/mitsubishi-deploys-arisglobal-new-pharmacovigilance-safety-solutions-300712/ 2012-07-29T22:29:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-wins-final-fda-approval-for-itraconazole-capsules-anda-300712/ 2012-07-30T00:45:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-clears-dr-reddys-mexico-chemical-manufacturing-facility-300712/ 2012-07-30T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-actemra-meets-primary-endpoint-in-brevacta-study-300712/ 2012-07-30T04:08:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-gains-european-approval-for-kalydeco-300712/ 2012-07-30T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/neurotez-receives-us-patent-for-hormone-leptin-300712/ 2012-07-30T04:42:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-use-of-braccos-multihance-injection-in-mra-300712/ 2012-07-30T06:14:00+00:00 https://www.pharmaceutical-business-review.com/news/absorption-systems-launches-new-bcrp-assay-system-300712/ 2012-07-30T07:29:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-commences-phase-3-epic-trial-of-ponatinib-300712/ 2012-07-30T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-files-xopenox-hfa-patent-lawsuit-against-watson-310712/ 2012-07-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ariad-seeks-fda-approval-for-leukemia-drug-310712/ 2012-07-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/vertex-hepatitis-c-drug-study-yields-positive-results-31-0712/ 2012-07-30T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/astellas-tokyo-institute-of-technology-sign-joint-research-agreement-310712/ 2012-07-30T19:43:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/psivida-signs-technology-evaluation-agreement-for-tethadur-310712/ 2012-07-30T20:33:00+00:00 https://www.pharmaceutical-business-review.com/news/coramrx-wins-urac-specialty-pharmacy-accreditation-310712/ 2012-07-30T23:24:00+00:00 https://www.pharmaceutical-business-review.com/news/bio-solutions-commences-production-of-type2-defense-310712/ 2012-07-31T00:59:00+00:00 https://www.pharmaceutical-business-review.com/news/alnylam-earns-development-milestone-payment-from-gsk-310712/ 2012-07-31T01:57:00+00:00 https://www.pharmaceutical-business-review.com/news/cytodyn-to-purchase-progenics-pro-140-anti-hiv-drug-310712/ 2012-07-31T04:14:00+00:00 https://www.pharmaceutical-business-review.com/news/tonix-completes-clinical-portion-of-tnx-102-sl-human-study-310712/ 2012-07-31T04:16:00+00:00 https://www.pharmaceutical-business-review.com/news/quintiles-to-promote-almirall-new-copd-drug-in-uk-310712/ 2012-07-31T04:50:00+00:00 https://www.pharmaceutical-business-review.com/news/basilea-submits-european-maa-for-anti-mrsa-drug-310712/ 2012-07-31T07:04:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-designation-to-exelixis-cabozantinib-310712/ 2012-07-31T07:07:00+00:00 https://www.pharmaceutical-business-review.com/news/study-says-otc-drug-sales-through-alternate-distribution-channels-increase-in-us-310712/ 2012-07-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/sunovion-unveils-zetonna-nasal-aerosol-for-allergic-rhinitis-310712/ 2012-07-31T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-oral-start-phase-3-study-meets-primary-end-point-010812/ 2012-08-01T00:34:00+00:00 https://www.pharmaceutical-business-review.com/news/orpro-wins-sbir-grant-to-advance-cystic-fibrosis-candidate-010812/ 2012-08-01T00:48:00+00:00 https://www.pharmaceutical-business-review.com/news/anchor-signs-collaborative-agreement-with-kyowa-010812/ 2012-08-01T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/xeris-to-advance-non-aqueous-glucagon-formulation-010812/ 2012-08-01T01:53:00+00:00 https://www.pharmaceutical-business-review.com/news/geno-wins-us-patents-for-nitric-oxide-delivery-technology-010812/ 2012-08-01T04:56:00+00:00 https://www.pharmaceutical-business-review.com/news/oncobiologics-signs-deal-with-xoma-for-fully-human-antibody-libraries-010812/ 2012-08-01T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/furiex-closes-priligy-asset-transfer-license-agreements-010812/ 2012-08-01T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/rcti-signs-exclusive-license-to-two-patents-from-nih-010812/ 2012-08-01T06:21:00+00:00 https://www.pharmaceutical-business-review.com/news/array-phase-2-trial-of-arry-797-meets-primary-endpoint-010812/ 2012-08-01T08:04:00+00:00 https://www.pharmaceutical-business-review.com/news/australia-receives-first-shipment-of-altrazeal-010812/ 2012-08-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-nupathe-migraine-patch-nda-resubmission-010812/ 2012-08-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/idenix-novartis-revise-collaboration-agreement-010812/ 2012-08-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/helsinn-thorne-launch-new-nutritional-portfolio-010812/ 2012-08-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/omeros-announces-pro-inflammatory-protein-discovery-010712/ 2012-08-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/adimab-mersana-partner-on-adc-technologies-020812/ 2012-08-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/ha-stops-saline-bottle-production-020812/ 2012-08-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/insite-vision-begins-bromsite-phase-3-study-020812/ 2012-08-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/abl-awards-contract-to-niaid-020812/ 2012-08-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/welichem-stiefel-acquire-new-anti-inflammatory-agent-020712/ 2012-08-01T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/cytochroma-to-deploy-omnicomm-eclinical-suite-for-phase-iii-studies-020812/ 2012-08-01T23:04:00+00:00 https://www.pharmaceutical-business-review.com/news/luitpold-selects-bioclinica-express-electronic-data-capture-system-020812/ 2012-08-01T23:06:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-watson-anda-for-budesonide-inhalation-suspension-020812/ 2012-08-02T00:23:00+00:00 https://www.pharmaceutical-business-review.com/news/acelrx-sufentanil-nanotab-pain-products-gain-additional-us-patents-020812/ 2012-08-02T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/navidea-signs-licensing-agreement-with-alseres-020812/ 2012-08-02T01:07:00+00:00 https://www.pharmaceutical-business-review.com/news/prosetta-bristol-myers-enter-into-multi-year-research-collaboration-020812/ 2012-08-02T04:39:00+00:00 https://www.pharmaceutical-business-review.com/news/nymox-bph-drug-shows-positive-treatment-outcomes-in-combined-statistical-analysis-020812/ 2012-08-03T00:21:00+00:00 https://www.pharmaceutical-business-review.com/news/prometic-nantpharma-form-nantpro-for-plasma-derived-product-development-020812/ 2012-08-03T00:28:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-new-patent-to-ziopharm-palifosfamide-drug-020812/ 2012-08-03T00:33:00+00:00 https://www.pharmaceutical-business-review.com/news/intellect-wins-noa-for-disease-modifying-therapeutic-agents-020812/ 2012-08-03T00:55:00+00:00 https://www.pharmaceutical-business-review.com/news/synta-announces-treatment-of-first-patients-in-alk-lung-cancer-trials-030812/ 2012-08-03T03:46:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-launches-new-vitamins-ad-supplement-030812/ 2012-08-03T04:46:00+00:00 https://www.pharmaceutical-business-review.com/news/oxygen-biotherapeutics-us-navy-to-study-oxycyte-for-treatment-of-hemorrhagic-shock-030812/ 2012-08-03T04:48:00+00:00 https://www.pharmaceutical-business-review.com/news/elusys-wins-barda-grant-for-eti-204-agent-development-030812/ 2012-08-03T06:35:00+00:00 https://www.pharmaceutical-business-review.com/news/janssen-supplies-doxil-to-support-endocyte-phase-3-proceed-trial-030812/ 2012-08-03T06:36:00+00:00 https://www.pharmaceutical-business-review.com/news/us-fda-approves-zaltrap-injection-030812/ 2012-08-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lipimetix-development-to-develop-apo-e-mimetic-peptide-aem-28-030812/ 2012-08-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/endocyte-smdc-approach-found-to-treat-adpkd-in-study-060812/ 2012-08-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/gsk-acquires-human-genome-sciences-060812/ 2012-08-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/healthpoint-biotherapeutics-announces-hp802-247-clinical-trial-results-060812/ 2012-08-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/lonza-signs-non-exclusive-license-agreement-with-ips-academia-080812/ 2012-08-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biodelivery-endo-starts-enrollment-in-bema-buprenorphine-phase-3-program-080812/ 2012-08-05T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biostar-wins-sfda-approval-to-restart-sales-of-gel-capsule-products-060812/ 2012-08-05T23:09:00+00:00 https://www.pharmaceutical-business-review.com/news/accenture-takes-over-octagon-research-solutions-060812/ 2012-08-06T00:10:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-begins-commercial-operations-in-india-with-arv-product-launch-060812/ 2012-08-06T01:04:00+00:00 https://www.pharmaceutical-business-review.com/news/cipla-to-build-active-pharmaceutical-ingredients-facilities-in-india-060812/ 2012-08-06T04:43:00+00:00 https://www.pharmaceutical-business-review.com/news/opko-health-takes-over-farmadiet-060812/ 2012-08-06T04:45:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phase-4-oab-study-meets-primary-endpoint-060812/ 2012-08-06T05:02:00+00:00 https://www.pharmaceutical-business-review.com/news/cevec-paragon-in-cap-technology-license-agreement-060812/ 2012-08-06T05:04:00+00:00 https://www.pharmaceutical-business-review.com/news/boehringer-servier-sign-gevokizumab-manufacturing-agreement-060812/ 2012-08-06T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/isis-california-facility-gains-gmp-certification-from-ema-060812/ 2012-08-06T06:03:00+00:00 https://www.pharmaceutical-business-review.com/news/marina-signs-non-exclusive-license-agreement-with-novartis-060812/ 2012-08-06T07:23:00+00:00 https://www.pharmaceutical-business-review.com/news/genocea-introduces-vaccine-for-herpes-simplex-virus-type-2-060812/ 2012-08-06T08:37:00+00:00 https://www.pharmaceutical-business-review.com/news/chiesi-to-market-kamada-alpha-1-antitrypsin-070812/ 2012-08-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-unveils-new-sterilizer-adv-070812/ 2012-08-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/neogenomics-unveils-neotype-cll-assay-070812/ 2012-08-06T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/phrma-analysis-group-select-mdso-cost-databases-for-clinical-trial-analysis-070812/ 2012-08-06T20:08:00+00:00 https://www.pharmaceutical-business-review.com/news/swog-to-deploy-sequenta-lymphosight-platform-070812/ 2012-08-06T20:46:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-pharma-to-shut-down-north-carolina-based-urology-research-facility-070812/ 2012-08-07T00:47:00+00:00 https://www.pharmaceutical-business-review.com/news/qualitest-introduces-generic-singulair-tablets-chewable-tablets-070812/ 2012-08-07T04:06:00+00:00 https://www.pharmaceutical-business-review.com/news/orni-signs-new-distribution-contract-with-central-business-usa-070812/ 2012-08-07T04:12:00+00:00 https://www.pharmaceutical-business-review.com/news/pharmaengine-nanobiotix-in-nbtxr3-radioenhancer-development-agreement-070812/ 2012-08-07T05:10:00+00:00 https://www.pharmaceutical-business-review.com/news/amneal-to-expand-manufacturing-operations-in-us-070812/ 2012-08-07T05:20:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-janssen-ai-discontinue-bapineuzumab-iv-phase-3-program-070812/ 2012-08-07T06:12:00+00:00 https://www.pharmaceutical-business-review.com/news/eternal-lifestyles-unveils-new-vitamins-supplements-product-line-070812/ 2012-08-07T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-viropharma-cinryze-industrial-scale-manufacturing-070812/ 2012-08-07T07:25:00+00:00 https://www.pharmaceutical-business-review.com/news/twi-completes-phase-iib-study-of-ac-201-070812/ 2012-08-07T08:27:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-mylan-anda-for-etomidate-injection-070812/ 2012-08-07T08:33:00+00:00 https://www.pharmaceutical-business-review.com/news/dana-farber-administers-kevetrin-070812/ 2012-08-07T08:41:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-specialty-pfizer-sign-epipen-injection-licensing-deal-in-japan-080812/ 2012-08-08T01:11:00+00:00 https://www.pharmaceutical-business-review.com/news/islet-sciences-spring-point-project-collaborate-for-transplantation-trial-08082012/ 2012-08-08T01:14:00+00:00 https://www.pharmaceutical-business-review.com/news/copd-foundation-announces-nhlbi-grant-for-second-phase-of-copdgene-project-080812/ 2012-08-08T01:18:00+00:00 https://www.pharmaceutical-business-review.com/news/theorem-clinical-research-gallus-partner-to-accelerate-rd-080812/ 2012-08-08T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/nektar-begins-investigator-sponsored-trial-of-etirinotecan-pegol-080812/ 2012-08-08T03:48:00+00:00 https://www.pharmaceutical-business-review.com/news/accu-break-alembic-in-new-accu-break-tablets-development-agreement-080812/ 2012-08-08T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/affinium-recruits-patients-in-phase-2-absssi-trial-080812/ 2012-08-08T06:55:00+00:00 https://www.pharmaceutical-business-review.com/news/epistem-signs-supply-distribution-agreement-with-becton-dickinson-080812/ 2012-08-08T07:05:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-wins-approval-for-phase-iii-muscle-regeneration-study-in-germany-080812/ 2012-08-08T08:15:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-cuts-greenhouse-gas-emissions-by-20-090812/ 2012-08-09T01:09:00+00:00 https://www.pharmaceutical-business-review.com/news/takeda-affymax-sign-supply-agreement-for-omontys-peginesatide-injection-090812/ 2012-08-09T01:15:00+00:00 https://www.pharmaceutical-business-review.com/news/aquavit-green-cross-sign-mou-on-ibx-001-090812/ 2012-08-09T02:35:00+00:00 https://www.pharmaceutical-business-review.com/news/perrigo-wins-final-fda-approval-for-morphine-sulfate-100ml5-oral-solution-090812/ 2012-08-09T02:37:00+00:00 https://www.pharmaceutical-business-review.com/news/schreiner-unveils-color-laser-film-label-for-dental-carpules-090812/ 2012-08-09T02:40:00+00:00 https://www.pharmaceutical-business-review.com/news/corcoran-compliance-lauches-new-ophthalmic-reimbursement-software-090812/ 2012-08-09T05:50:00+00:00 https://www.pharmaceutical-business-review.com/news/dicerna-achieves-milestone-in-research-collaboration-with-kyowa-hakko/ 2012-08-09T05:59:00+00:00 https://www.pharmaceutical-business-review.com/news/neurostrong-launches-new-mental-focus-supplement-090812/ 2012-08-09T06:02:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-announces-availability-of-male-enhancement-supplement-090812/ 2012-08-09T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/synthetic-biologics-intrexon-enter-exclusive-channel-collaboration-for-infectious-diseases-090812/ 2012-08-09T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/bristol-myers-astrazeneca-expand-diabetes-alliance-100812/ 2012-08-10T00:54:00+00:00 https://www.pharmaceutical-business-review.com/news/nodality-pfizer-collaborate-to-use-scnp-technology-100812/ 2012-08-10T01:46:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-announces-us-re-launch-of-generic-eloxatin-100812/ 2012-08-10T02:15:00+00:00 https://www.pharmaceutical-business-review.com/news/tigenix-completes-patient-enrolment-in-cx611-phase-iia-study-100812/ 2012-08-10T03:55:00+00:00 https://www.pharmaceutical-business-review.com/news/teva-active-biotech-to-begin-phase-iii-study-of-oral-laquinimod-100812/ 2012-08-10T05:05:00+00:00 https://www.pharmaceutical-business-review.com/news/uspto-grants-patent-to-aeterna-oral-ghrelin-agonist-100812/ 2012-08-10T07:11:00+00:00 https://www.pharmaceutical-business-review.com/news/cytosorbents-to-develop-broad-spectrum-polymer-for-sepsis-treatment-100812/ 2012-08-10T07:16:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-accelerated-approval-to-talon-vincristine-sulfate-injection-100812/ 2012-08-10T07:18:00+00:00 https://www.pharmaceutical-business-review.com/news/protalix-biotherapeutics-to-initiate-prx-102-clinical-trials-130812/ 2012-08-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/bosch-packaging-opens-new-manufacturing-facility-in-india-170812/ 2012-08-12T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-lucentis-injection-wins-fda-clearance130812/ 2012-08-13T01:21:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-final-approval-to-mylan-modafinil-tablets-anda-130812/ 2012-08-13T02:59:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-teams-up-with-dupetit-to-expand-in-europe-130812/ 2012-08-13T04:36:00+00:00 https://www.pharmaceutical-business-review.com/news/mylan-introduces-lithium-carbonate-extended-release-tablets-usp-130812/ 2012-08-13T04:59:00+00:00 https://www.pharmaceutical-business-review.com/news/genentech-phase-iii-avaglio-study-meets-co-primary-endpoint-130812/ 2012-08-13T05:06:00+00:00 https://www.pharmaceutical-business-review.com/news/antigen-discovery-to-identify-biomarkers-associated-with-protection-against-malaria-130812/ 2012-08-13T08:55:00+00:00 https://www.pharmaceutical-business-review.com/news/multicell-announces-new-cancer-therapeutics-preclinical-results-130712/ 2012-08-13T08:57:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-phase-3-intoract-trial-fails-to-meet-endpoint-130812/ 2012-08-13T08:58:00+00:00 https://www.pharmaceutical-business-review.com/news/meritage-pharma-begins-obs-phase-ii-clinical-trial-160812/ 2012-08-13T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/pfizer-signs-deal-with-astrazeneca-for-nexium-otc-rights-140812/ 2012-08-14T01:05:00+00:00 https://www.pharmaceutical-business-review.com/news/saic-takes-over-maxit-healthcare-140812/ 2012-08-14T01:06:00+00:00 https://www.pharmaceutical-business-review.com/news/astellas-astrazeneca-announce-symbicort-turbuhaler-approval-in-japan-140812/ 2012-08-14T01:08:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-accepts-teva-quartette-new-drug-application-140812/ 2012-08-14T03:59:00+00:00 https://www.pharmaceutical-business-review.com/news/scripsamerica-completes-rd-phase-of-rapimed-140812/ 2012-08-14T04:00:00+00:00 https://www.pharmaceutical-business-review.com/news/acorda-reports-negative-top-line-results-of-study-exploring-ampyra-5mg-efficacy/ 2012-08-14T04:25:00+00:00 https://www.pharmaceutical-business-review.com/news/laureate-partners-with-zz-biotech-for-new-stroke-drug-production-140812/ 2012-08-14T06:24:00+00:00 https://www.pharmaceutical-business-review.com/news/molecular-profiles-join-forces-with-onyx-scientific-140812/ 2012-08-14T06:27:00+00:00 https://www.pharmaceutical-business-review.com/news/ranbaxy-shifts-atorvastatin-production-to-india-140812/ 2012-08-14T06:33:00+00:00 https://www.pharmaceutical-business-review.com/news/antigen-discovery-wins-sbir-award-140812/ 2012-08-14T08:51:00+00:00 https://www.pharmaceutical-business-review.com/news/cannabis-science-initiates-cs-tati-1gmp-development-plan-140812/ 2012-08-14T08:52:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-approves-auvi-q-injection-140812/ 2012-08-14T08:56:00+00:00 https://www.pharmaceutical-business-review.com/uncategorized/cato-research-pluristem-collaborate-on-ic-phase-ii-trial-140812/ 2012-08-14T09:07:00+00:00 https://www.pharmaceutical-business-review.com/news/soricimed-initiates-phase-i-trial-of-sor-c13-150812/ 2012-08-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/coronado-biosciences-initiates-trust-i-clinical-trial-150812/ 2012-08-14T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/morphotek-opens-new-manufacturing-plant-in-us-150812/ 2012-08-14T23:48:00+00:00 https://www.pharmaceutical-business-review.com/news/nouveau-life-unveils-new-calcium-vitamin-d-supplements-150812/ 2012-08-14T23:50:00+00:00 https://www.pharmaceutical-business-review.com/news/regulus-partners-with-astrazeneca-for-microrna-therapeutics-150812/ 2012-08-14T23:55:00+00:00 https://www.pharmaceutical-business-review.com/news/wockhardt-wins-marketing-approval-for-generic-bph-drug-150812/ 2012-08-15T00:09:00+00:00 https://www.pharmaceutical-business-review.com/news/aptalis-launches-viokace-tablets-in-us-150812/ 2012-08-15T01:40:00+00:00 https://www.pharmaceutical-business-review.com/news/fda-grants-orphan-drug-designation-to-geno-inhaled-no-drug-platform-150812/ 2012-08-15T03:07:00+00:00 https://www.pharmaceutical-business-review.com/news/upsher-smith-laboratories-takes-over-proximagen-group-150812/ 2012-08-15T03:09:00+00:00 https://www.pharmaceutical-business-review.com/news/zenobia-therapeutics-forms-strategic-alliance-with-addf-150812/ 2012-08-15T03:15:00+00:00 https://www.pharmaceutical-business-review.com/news/cellular-dynamics-ceetox-unveil-new-cardiac-screening-service-150812/ 2012-08-15T06:06:00+00:00 https://www.pharmaceutical-business-review.com/news/onconatural-prostate-cancer-treatment-wins-us-patent-150812/ 2012-08-15T06:07:00+00:00 https://www.pharmaceutical-business-review.com/news/merck-arrowhead-to-evaluate-antibody-candidate-150812/ 2012-08-15T06:09:00+00:00 https://www.pharmaceutical-business-review.com/news/japan-grants-patent-to-anticancer-drug-lor-253-150812/ 2012-08-15T06:16:00+00:00 https://www.pharmaceutical-business-review.com/news/medicago-idri-to-conduct-influenza-vaccine-clinical-trial-160812/ 2012-08-15T18:30:00+00:00 https://www.pharmaceutical-business-review.com/news/biogen-regulus-to-explore-micrornas-as-biomarkers-for-multiple-sclerosis-160812/ 2012-08-16T00:57:00+00:00 https://www.pharmaceutical-business-review.com/news/apexigen-seeks-ind-approval-of-apx001-160812/ 2012-08-16T01:27:00+00:00 https://www.pharmaceutical-business-review.com/news/nanoviricides-reports-effectiveness-of-oral-anti-influenza-drug-160812/ 2012-08-16T01:35:00+00:00 https://www.pharmaceutical-business-review.com/news/ims-health-completes-acquisition-of-ttc-160812/ 2012-08-16T02:23:00+00:00 https://www.pharmaceutical-business-review.com/news/cordlife-ccbc-to-offer-cord-blood-storage-services-160812/ 2012-08-16T03:16:00+00:00 https://www.pharmaceutical-business-review.com/news/genocea-commences-phase-12a-study-of-gen-003-160812/ 2012-08-16T04:13:00+00:00 https://www.pharmaceutical-business-review.com/news/pluristem-wins-approval-for-phase-ii-buergers-disease-trial-in-india-160812/ 2012-08-16T04:19:00+00:00 https://www.pharmaceutical-business-review.com/news/senesco-completes-first-cohort-of-patients-in-phase-1b2a-multiple-myeloma-trial-160812/ 2012-08-16T06:05:00+00:00 https://www.pharmaceutical-business-review.com/news/gsk-to-divest-majority-of-classic-brands-in-australia-160812/ 2012-08-16T06:53:00+00:00 https://www.pharmaceutical-business-review.com/news/cambrex-signs-active-pharmaceutical-ingredient-supply-agreement-160812/ 2012-08-16T07:43:00+00:00 https://www.pharmaceutical-business-review.com/news/hospira-recalls-hydromorphone-injection-at-user-level-160812/ 2012-08-16T07:49:00+00:00 https://www.pharmaceutical-business-review.com/news/renaissance-pharma-wins-denavir-rights-in-us-160812/ 2012-08-16T07:56:00+00:00 https://www.pharmaceutical-business-review.com/news/watson-sues-us-fda-over-delay-of-generic-actos-approval-160812/ 2012-08-16T07:58:00+00:00